Stock Optionen Vest Über 4 Jahre

Dieses Gipfeltreffen deckt die neuesten handels - und technologischen Herausforderungen, die die Buy-Side in einer sich ständig verändernden Finanz - und Regulierungslandschaft betreffen, sowie innovative Strategien zur Optimierung der Handelsabwicklung, Risikomanagement und Steigerung der operativen Effizienz bei gleichzeitiger Minimierung der Kosten. WatersTechnology und Sell-Side Technology freuen sich, den 7. jährlichen North American Trading Architecture Summit zu präsentieren. Zusammenführung von Technologen, Architekten, Softwareentwicklern und Rechenzentrumsleitern aus der Finanzwelt, um die neuesten Fragen der Handelstechnologie zu diskutieren. Datum: 05 Apr 2017 New York Marriott Marquis, New York Tokio Finanzinformationstechnologie Gipfel Waters Technology2: 39 Uhr Apogee Enterpr erhöht Quartalsdividende auf 0,14share von 0,125share (APOG). 14:04 Boeing und Jeju Air kündigten heute einen Auftrag für drei Next-Generation 737-800 an. Der Auftrag wurde auf fast 300 Millionen (BA) geschätzt. Der Auftrag, geschätzt bei fast 300 Million zu den gegenwärtigen Listenpreisen, wird die Fluglinien erste direkt gekaufte Flugzeuge von Boeing und Treibstoff die Fluglinien fortfuhren Expansion in Asias schnell wachsendem Flugreisenmarkt. Die Bestellung wurde zuvor einem unbekannten Kunden auf der Website von Boeings Orders amp Deliveries zugeschrieben. 1:18 Uhr Earnings-Kalender für Dienstag, 10. Januar (: SUMRX). Heute nach dem nahen Blick für die folgenden Unternehmen zu berichten: SNX, LMNRTermorrow vor dem offenen Blick für die folgenden Unternehmen zu berichten: SVU, MSM 13.12 Uhr General Motors auf der Deutschen Bank-Konferenz sagt, dass es 16 EPS auf High-End der vorherigen Anleitung sieht Bereich sieht FY17 EPS über Erwartungen genehmigt zusätzliche 5 bln LagerrückkäufeE (GM). Co Fragen in-line-Guidance für FY16 (Dez), sieht EPS von High-End von 5,50-6,00 vs 6,01 Capital IQ Consensus Schätzung. Co beauftragt nach oben Guidance für FY17 (Dez), sieht EPS von 6.00-6.50 vs 5.70 Capital IQ Consensus Estimate. Basiert auf diese starke Aussichten, genehmigte der GM Board of Directors zusätzliche 5 Mrd. Aktien Rückkäufe im Rahmen ihrer bestehenden Aktienrückkauf-Programm , Die am 9. März 2015 angekündigt wurde. Die neue Genehmigung, die kein Ablaufdatum hat, bringt die Gesamtkosten im Rahmen des Programms auf 14 Milliarden. GM kündigte auch eine Erhöhung um 1 Milliarde an seinem Kosten-Nutzen-Ziel an und erhöhte es auf 6,5 Milliarden bis 2018, Von denen rund 4,0 Mrd. bereits bis 2016 erreicht wurden. Die erhöhte Schätzung basiert auf erwarteten zusätzlichen Einsparungen bei Material-, Logistik-, Fertigungs - und allgemeinen Verwaltungskosten 1:07 pm Midday Market Summary: Wichtige Durchschnitte Stable, Just Below Session Highs (: WRAPX ): Die Hauptdurchschnitte sitzen gerade unter ihren Sitzungshöhen früh dieser Nachmittag. Die SampP 500 ist um 0,3, während die Nasdaq (0,5) bleibt vor seinen Kollegen. Die Börse begann den Handelstag etwas niedriger nach vielen Einzelhändlern und Restaurants ausgestellt enttäuschende Beratung. Allerdings wurden die Anliegen durch den Markt abgetan, belegt durch den 1,5 Anstieg in der SPDR SampP 500 Retail ETF (XRT 44,46, 0,66). Die Konsumgüterbranche ist ebenfalls um 0,6 gestiegen. Kurz vor dem Konsum ist der Finanzsektor (0,9) der Spitzenreiter. Gesundheit und Industrien folgen nah, beide herauf nahe 0.7. Der industrielle Sektor wurde von einem Aufwärtstrend in den Fluglinien nach Alaska Air (ALK 92.33, 4.86) von besser als erwartete Dezember-Verkehrsdaten berichtet. Alaska Air ist um 5,5 gestiegen, während Delta Air Lines (DAL 51.16, 1.46), Southwest Airlines (LUV 51.59, 1.29), American Airlines (AAL 48.02, 0.95) und United Continental (UAL 73.42, 2.15) 3,0. Der breitere Dow Jones Transport Durchschnitt handelt höher um 1.1. Der Top-bewertete Technologie-Sektor (0,2) handelt ein wenig hinter dem breiteren Markt, aber die Chiphersteller zeigen eine relative Stärke. Der PHLX Semiconductor Index (0,4) übertrifft leicht, aber der breitere Sektor wurde durch schwache Leistungen von Schwergewichten wie Apple (AAPL 119.12, 0,12) und Facebook (FB 62.82, 0,18) zurückgehalten. Immobilien ist unbestritten an der Unterseite der heutigen Wertung, mit einem Verlust von 1,0. Die Sektoren, die den zyklischen Konkurrenten - Verbraucher-Heftklammern und Dienstprogrammen - näher sind ihren flachen Linien, aber sind noch unten 0.3 und 0.2. Die drei Sektoren und Energie sind die einzigen Räume im negativen Gebiet für das Jahr. Energie (unch) hat sich an seine flache Linie in einem Versuch, Rohöl 1,0 Abwärtshaken zu klammern. Der Rohstoffhandel in der Nähe seiner Sitzung niedrig bei 51.43bbl. Um mehr Druck auf die Energiekomponente auszuüben, erreichte der US-Dollar-Index (102,06, 0,14) ein positives Territorium in der jüngsten Aktion, nachdem er den Morgen im Roten verbracht hatte. Die Zuwächse resultieren aus einer relativen Schwäche im Euro (1.0557). Treasuries sind wenig verändert mit der 10-yr Ertrag um einen Basispunkt bei 2,38. Überprüfung der heutigen wirtschaftlichen Daten: November Wholesale Vorräte erhöht 1,0, die über dem Briefing Konsens von 0,9 war. Die vorangegangenen Monate wurden auf -0,1 von -0,4 überarbeitet. November Job-Eröffnungen und Arbeitsumsatz Umfrage ergab, dass die Stellenangebote sank von 5,151 Millionen (von 5,534 Millionen) im Oktober auf 5,193 Millionen im Jahr auf 5,193 Millionen. Für mehr über diese wirtschaftlichen Veröffentlichungen, sollten Sie unbedingt besuchen Briefings Wirtschaftskalender 1:03 pm Tonix Pharma Details seiner Vor kurzem erweitert Produktpipeline auf der 9. jährlichen Biotech ShOWCASE KONFERENZ (TNXP). Co sagte, wir sind bereit, im ersten Quartal 2017 die Phase 3 HONOR Studie von TNX-102 SL für militärbezogene posttraumatische Belastungsstörung (: PTSD) beginnen. Wir sind zuversichtlich, dass wir im vierten Quartal 2017 unser erstes Ergebnis erzielen können. quot 1:01 pm Pfizer kündigt ein Forschungskooperationsabkommen mit den Scripps Research Instituts FINANCIAL TERMS NOT DISCLOSED (PFE) an. Unter den Bedingungen der Zusammenarbeit zahlt Pfizer eine Technologiezugangsgebühr und erhält dadurch Zugang zu der innovativen chemischen Synthesetechnologie, die bei TSRI entwickelt wurde. Mitglieder der TSRI-Chemie-Professoren Phil Baran, Ph. D. Dale Boger, Ph. D. Jin-Quan Yu, Ph. D. K. Barry Sharpless, Ph. D. Und andere - werden zusammen mit den Pfizer-Wissenschaftlern arbeiten, um diese chemischen Methoden für die Herstellung von DELs anzupassen, die strenge Prozesse erfordern, die gegenüber dem empfindlichen DNA-Backbone tolerant sind. TSRI und Pfizer können beschließen, den Geltungsbereich der gemeinsamen Forschung auf andere Technologien auszuweiten, die für die Ermöglichung der DEL-basierten Wirkstoffforschung relevant sind. Finanzielle Bedingungen der Vereinbarung werden nicht bekannt gegeben. 1:01 pm Network-1 kündigt USPTO-Ausgabe von Patenten im Zusammenhang mit seinen Cox-Portfolio-Ansprüche in der neu herausgegebenen Patent sind in der Regel auf Systeme der Inhalt Identifizierung und Durchführung von Maßnahmen nach NTIP gerichtet. 12:21 Uhr Novadaq Tech. LifeNet Healths Dermacell azelluläre dermale Matrix zeigte statistisch signifikante Verbesserungen im Vergleich zu AlloDerm Ready-to-Use nach den Ergebnissen einer Studie, die von der JOURNAL PLASTIC Amp RECONSTRUCTIVE SURGERY (NVDQ): Die RETROSPEKTIVE STUDIE, quotComparison der verschiedenen Acellular Dermal Matrix (ADM) In der Brustrekonstruktion: Die 5050 Studie1, verglichen klinischen Ergebnisse zwischen Dermacell und AlloDerm RTU in der Brustrekonstruktion - die neueste empirische Studie, um direkt vergleichen Sie die beiden Transplantate. Fünfundachtzig Patienten unterzogen Rekonstruktionsverfahren entweder mit Dermacell (30 Patienten, 50 Brüste) oder AlloDerm RTU (28 Patienten, 50 Brüste). Derselbe Chirurg führte alle Rekonstruktionen durch. Unterschiede im Patienten-Durchschnittsalter, Body Mass Index, Prozent der Patienten mit neo-adjuvantadjuvant Chemotherapie oder Brust-Bestrahlung und die Zahl der therapeutischen und prophylaktischen Mastektomien zwischen den beiden Patientengruppen war nicht statistisch signifikant. Komplikationen in beiden Gruppen wurden für 90 Tage nach der Rekonstruktion aufgezeichnet. Die Autoren berichteten, dass die Patienten in der Dermacell-Gruppe im Vergleich zur AlloDerm-Gruppe eine statistisch signifikante Verbesserung der Inzidenz des Red Breast-Syndroms zeigten - bei null Fällen unter den Dermacell-Empfängern im Vergleich zu 13 bei AlloDerm RTU - 15,8 Tage versus 20,6). Darüber hinaus stellten die Autoren keinen signifikanten Unterschied in Bezug auf Serom, Hämatom, verzögerte Heilung, Infektion, Flap Nekrose und Explantation. Dermacell wird von LifeNet Health verarbeitet und vertrieben von NOVADAQ Technologies 12:14 pm Floor Talk: Resilience (: TALKX): Ein vorläufiger Start hat sich zu einem festen Vorsprung entwickelt, angetrieben von einer anständigen Führung aus dem finanziellen (0.9), der Industrie (0,7), Konsumgüter (0,7) und Gesundheitswesen (0,6). Allerdings ist es die Märkte Resilienz zu verkaufen Bemühungen, die weiterhin als die Untermauerung Faktor in Kauf Bemühungen zu handeln. Einige handelbare Fälle sind heute die folgenden: Die Outperformance der Russell 2000 (1,0), die hinter dem Montag mit einem Rückgang von 0,7 zurückblieb. Die relative Stärke des Konsumgütersektors trotz einer Spate von salesearnings Warnungen von einer Anzahl von Facheinzelhandelspartnern der SPDR SampP Retail ETF (XRT 44.44, 0.62, 1.4) übertrifft die relative Stärke der Transporte, die laggards im Frühjahr 2017DJTA ist bis 1,2 nach dem Eintritt in den heutigen Trade Down 0,2 im Jahr 2017Upside Führung von den Finanzen im Angesicht einer Citigroup Downgrade von Goldman Sachs (GS (BAC 22.96, 0.41, 1.8), JPMorgan Chase (JPM 86.56, 0.41, 1.8) von Neutral und einem Goldman Sachs-Downgrade von Reisenden (TRV 117.58, 0.26, 0.2) 0,8, 0,4), und Wells Fargo (WFC 54,99, 0,75, 1,4) sind auch alle Handelsplätze höher als vor ihrem Ergebnis berichtet dieser FreitagDer Energiesektor (0,1) hält trotz eines weiteren Rückgangs der Rohpreise (-0,9 bis 51,50 bbl) Faktor der Widerstandsfähigkeit fährt fort, die Furcht vor dem Fehlen auf weiteren Gewinnen zu füttern. Eine Reihe von Teilnehmern war wahrscheinlich erwarten einige zusätzliche Nachteile auf den Fersen von Mondays negativen Ausflug für den breiteren Markt, aber wenn die Follow-Through nicht in großem Ausmaß zu materialisieren, schuf es einige drückende Maßnahmen, die dazu beigetragen, drücken Sie die wichtigsten Indizes höher (und Im Falle der Nasdaq weiter in das Rekordgebiet. 11:58 Uhr Europäische Märkte schliessen (: SUMRX). Preise Die europäischen Märkte sind inzwischen geschlossene Aktienmärkte in ganz Europa: UKs FTSE: 0,5 Deutschlands DAX: 0,2 Frances CAC: 0,0 Spains IBEX: -0,4 Portugals PSI: -1,3 Italys MIB Index: 0,3 Irish Ovrl Index: 0,3 Griechenland ASE General Index : 0,2 11:41 am Basismetalle, Fluggesellschaften, Silber, Einzelhandel, homebuildeRS, BANKEN UND TRANSPORTE FÜHREN DES MARKTS HÖHER MIT REITS, ENERGIE UND STAPLES LAGGING VS. SPY 0,3 (SPY). XME 3,24 JETS 2,20 SLV 1,85 XRT 1,22 KRE 1,16 ITB 1,19 KBE 1,15 IYT 1,10 IWM 1,04 HACK 1,13XLRE -0,95 OIH -0,55 IYR -0,53 USO -0,53 XLP -0,36 11:41 am Titan Intl wird ein Post-Hearing-Brief am Januar einreichen 11 in Bezug auf seine Verletzung, bevor der ITC OPTIMISTISCH ERHOBEN HAT, DASS DER ITC IN DIESEN FÄLLEN (TWI) EINE SCHLUSSBESTIMMUNG BESTIMMT. 11:08 AM TENNECO IST ZUR REINIGEN LUFTTECHNOLOGIE AUF DER NEUEN DAIMLER (DDAIF) NRM Motorenfamilie (TEN). 10:37 Uhr Bemerkenswerte Interessenten: ILMN 15 als Co bestätigt Einführung der NovaSeq-Serie (SCANX): Im Folgenden sind einige der aktuell bekanntesten Interessenten, die nach Marktkapitalisierung kategorisiert sind (Großkapital von über 10 Milliarden und Mid Caps zwischen 2 -10 Milliarden) und rangiert durch Veränderung (alle Bestände über 100K durchschnittlichen täglichen Volumen). Large Cap Gainers ILMN (162.85 15.06): Bestätigt die Einführung der NovaSeq-Serie, eine neue und skalierbare Sequenzierungsarchitektur, die eines Tages erwartet wird, um die Illumina Bio-Rad Single-Cell Sequencing-Lösung von Illumina und Bio-Rad Laboratories zu starten. ZBH (113.01 5.62): sieht Q4 Umsatz über Konsens, sieht FY16 EPS am oberen Ende der vorherigen guidance. CMG (410.04 3.79): Aktien handeln höher trotz Warnung auf das Ergebnis als Umsatz verbessert inmitten leichter Comps Large Cap Verlierer WMB (28.9 -9.49) : Preise 65 Mio. Aktien der Stammaktie bei 29,00 Share. MCO (94.49 -2.45): Herabgestuft auf Neutral von UBS. Mid Cap Gainers VRX (16.78 9.33): Verteilt seine CeraVe, AcneFree und AMBI Skincare Marken an LOreal (LRLCY) für 1,3 Milliarden, um Dendreon für 819,9 Millionen zu veräußern. MDRX (11,73 8,81): bekräftigt Q4-Anleitung und gibt erste Aussichten für 2017. W (40,96 7,65): Auf der ICR-Konferenz war die gesamte Urlaubszeit ziemlich stark ist der Ansicht, es ist nahe, freien Cashflow positiv auf eine nachhaltige Basis. Mid Cap Verlierer KITE (49.73 -4.35): Enters in eine strategische Partnerschaft mit Daiichi Sankyo Co für axicabtagene ciloleucel. ENDP (15.77 -3.9): FDA plant Beratungsausschuss Sitzung zu diskutieren Sicherheitsfragen für die neue Droge aPPLICATION FÜR OPANA ER (OXYMORPHONE HYDROCHLORIDE) EXTENDED-RELEASE TABLETTEN. 10:02 AM ALLIANCE MMA ERWERBET SUCKERPUNCH ENTERTAINMENT FINANZDATEN NICHT GESCHLOSSEN (AMMA). 9:47 am Eröffnungsmarkt Zusammenfassung: Hauptdurchschnitte geöffnete Wohnung (: WRAPX): Die Hauptdurchschnitte begannen den Handelstag nahe ihren flachen Linien mit dem SampP 500 niedriger durch 0.1. Der Gesundheitssektor (0,3) ist vorne, die übrigen nicht-zyklischen Gruppen unterdurchschnittlich. Immobilien, Telekommunikationsdienste, Versorger und Konsumgüter liegen alle zwischen 0,3 und 0,7. Auf der zyklischen Seite befinden sich fünf von sechs Sektoren im positiven Bereich. Energie (-0,3) baut den Trend trotz einer bescheidenen 0,2 Gewinne in Rohöl. WTI Rohhandel bei 52.06bbl. Die Treasuries sind nach dem frühen VERKAUFSDRUCK in ihre flache Linie zurückgekehrt. DAS 10-YR-RENDITE WIRD AM 2.37 VERÄNDERT. 9:38 AM BIOCEPT ERKLÄRT, DASS ES EIN SICHERES IN-NETZWERK-ANBIETERVERTRAG MIT BLAUEM KREUZBLAUEM SHIELD VON TEXAS-BEDINGUNGEN NICHT AUSGESCHLOSSEN HAT (BIOC). "Partnering mit Krankenversicherern ist ein wichtiger Schwerpunkt unserer Geschäftsstrategie, da es den Arzt Zugang zu dieser nicht-invasiven Technologie für ihre Patienten und rechtzeitige Entscheidung über die Ansprüche für Patienten. Die Sicherung dieser In-Netzwerk Vereinbarung ist ein wichtiger Meilenstein für Biocept, denn Texas ist einer unserer größten Märkte und BCBSTX ist der größte Anbieter in diesem Land. Mit dieser Vereinbarung ist die Zahl der Patienten mit In-Netzwerk-Zugang zu unseren Tests auf etwa 185 Millionen gewachsen, mit einigen Mitgliedern, die über mehrere Pläne Zugriff haben. Quot 9:29 am On The Wires (: WIRES). Xplore Technologies Corp. (XPLR) gab bekannt, dass es mit CLS America zusammengearbeitet hat, um das Thorium X zu starten, ein erstklassiges Satellitenkommunikationstablettsystem, das auf dem Xplore XSLATE D10 Android Rugged Tablet PC basiert. Xplore erhielt eine Erstbestellung vom OEM-Kunden CLS für 1.000 XSLATE D10-Einheiten und ist bereit, Folgeaufträge zu erfüllen, wie es in den nächsten drei Jahren erforderlich ist, um die steigende Produktion und den Vertrieb des CLS-Markensystems, wie es die Nachfrage nach Endbenutzern erfordert, zu unterstützen. TapImmune, Inc. (TPIV) kündigte die Eröffnung der Phase-2-Unternehmens-gesponsert Eierstockkrebs-Studie in Platin-empfindliche Eierstockkrebs-Patienten. Die Unternehmen die ersten drei klinischen Standorten haben Regulierungsbehörde und Investigational Review Board (: IRB) Genehmigung für die Immatrikulation zu starten. Die Studie wird TPIV 200 einsetzen, eine T-Zell-Therapie, die auf das Folatrezeptor-Alpha-Protein abzielt. SPS Commerce (SPSC) amp Deposco kündigte eine Partnerschaft an, die Einzelhändlern die Möglichkeit gibt, über die Beschränkungen der Legacy-Supply-Chain-Lösungen hinauszugehen und die digitale Einzelhandelserfüllung zu optimieren. Zusammen bringen die Unternehmen neue Fähigkeiten, die Einzelhändler den erhöhten Einkaufsanforderungen gerecht werden müssen, wie z. B. Schiff aus dem Ladengeschäft und Online-Kauf, vereinfachte eine Vereinbarung mit dem MONROE COUNTY CONTROL CENTER in PENNSYLVANIA FÜR TYLER NEW WORLD PUBLIC SICHERHEIT COMPUTER-AIDED DISPATCH (CAD) - Lösung. Die Vereinbarung umfasst Software-Implementierung, Schulung, Daten-Datei-Konvertierung und Notfall 247 CAD Wartung. 9:28 am Simpson Manufacturing erwirbt CG Visions für bis zu 21,5 mln (SSD). Das Unternehmen kündigte an, dass es vor kurzem erworben CG Visions, Inc. ein US-Unternehmen BIM (Building Information Modeling) - Technologie, Dienstleistungen und Beratung für die Wohnbranche. Mit der strategischen Akquisition soll Simpson Strong-Tie seine Partnerschaften mit Top-Herstellern im ganzen Land vertiefen, indem es skalierbare und flexible BIM-Softwarelösungen anbietet, die den Bauunternehmern helfen, die Kosten zu steuern und die Effizienz in jedem Stadium des Hausbauprozesses zu erhöhen. Das Unternehmen schloss die Akquisition für bis zu rund 21,5 Milliarden ab, einschließlich einer Ausschüttung in Höhe von 2,15 Milliarden, die auf die Erfüllung von Vertriebszielen ausgerichtet ist und sich an spezifische HOLDBACK-BESTIMMUNGEN und POST-CLOSING-ANPASSUNGEN HINZUFÜGT. 9:24 AM CENTERSTATE BANKEN VON FLORIDA ANNOUNCED PREISE SEINES 2.45 MLN COMMON STOCK ANGEBOT (CSFL). Co gab bekannt, dass es 2.450.000 Aktien seines Stammkapitals an Keefe, Bruyette amp Woods, A Stifel Company und Raymond James amp Associates verkauft hat, als undeRWRITERS FÜR SEIN VORHER ANGEGEBENES ÖFFENTLICHES ANGEBOT. CENTERSTATE VERWENDET DAS NET DURCH DIESES ANGEBOT FÜR ALLGEMEINE GESCHÄFTSFELDER. 9:19 PM JOHN HOLZ-GRUPPE PLC SICHERET MULTI-MILLION DOLLAR RAHMENVERTRAG MIT SAUDI ARAMCO (WDGJF). Co hat eine Fünf-Jahres-, Multi-Millionen-Dollar-Rahmenvereinbarung, um die Ingenieur-und Projektmanagement-Dienstleistungen für SaudiAramcos Onshore-Kapital-Programme im Königreich Saudi-Arabien. Effective sofort, der Vertrag umfasst auch drei, ein Jahr Erweiterungsoptionen und wird vor Ort geliefert werden in Saudi-Arabien. ERSTE VERGEBEN IM 2010, DIE GENERAL ENGINEERING SERVICE PLUS CONTRACT EXTENSION WIRD VON HOLZGRUPPEN BÜRO IN AL KHOBAR BESUPPORTIERT. 9.15 Uhr GENIE ENERGY ERKLÄRT, DASS DAS IHR EISENBAHNBOHREN IST, EINE AUF DEM BODEN IN ISRAEL (GNE). Atid wird die Bohrmöglichkeiten für Kunden in einer Vielzahl von Bereichen, einschließlich Öl-und Gas-Exploration, Wasserressourcen-Entwicklung und Mineral Exploration. Atid hat eine bindende MOU durchgeführt, um eine Bohranlage und zugehörige Bohrgeräte erwerben. Das Bohrgerät hat in den letzten zwei Jahren fünf Explorationsöl - und Gasbohrlöcher in den Golanhöhen erfolgreich gebohrt und vor kurzem eine Wasserquelle fertiggestellt, die darauf ausgerichtet ist, Landwirten im Golan zu helfen, die eine ausgedehnte Dürre bewältigen. Aidid erwartet eine Partnerschaft mit internationalen Bohrdiensten Experten, darunter Regenmacher, eine Partnerschaft von nordamerikanischen Öl - und Service-Provider Gasbohrungen mit Sitz in West Canada. Atid wird erwartet, dass seine erste Explorationsbohrung Anfang März fÜR AFEK Öl und Gas, die GENIE-ENERGIE, DIE TOCHTERGESELLSCHAFT führt eine Öl und Gas zu spud EXPLORATORIELLES PROGRAMM IN DEN GOLENISCHEN HÖHEN. 9:13 AM EUROSEAS ERKLÄRT, DASS ES ZU LIEFERUNG DER VORHERGESCHLOSSENEN AKQUISITION VON MV TASOS, einem 75,100 DWT PANAMAX DRYBULK CARRIER (ESEA), ankündigt. 9:13 am SampP Futures gegen den beizulegenden Zeitwert: 0,80. Nasdaq Futures gegenüber dem Fair Value: 0,40. (: WRAPX): Die Börse ist auf Kurs für eine Flat-Eröffnung, da der SampP 500 Futures-Handel einen Punkt über dem Fair Value liegt. Im Vor-Markt-Handel ist Chipotle Mexican Grill (CMG 412.00, 16.94) höher als 4.3 trotz der Ausgabe Nachteilführung. Illumina (ILMN 161.53, 19.99) ist auch tickende bis, spiking 14.1 nach der Ausgabe über Konsensus Ertragsberatung für das vierte Quartal. Umgekehrt, Williams Companies (WMB 28,62, -3,28) hat 10,3 nach der Preisgestaltung ein zweites Angebot gefallen. Darüber hinaus wurde die Aktie auf Hold von Buy bei Jefferies herabgestuft. Nach einem optimistischen Start in die Woche, U. S. Treasuries sind unter bescheidenen Verkauf Druck früh heute Morgen. Die 10-jährige Ausbeute ist um zwei Basispunkte bei 2,39 höher. Die heutigen Wirtschaftsdaten werden auf die November-Job-Öffnungen (: JOLTS) und November Großhandel Vorräte (Briefing Konsens 0,9) begrenzt werden. Beide Berichte werden um 10:00 Uhr ET veröffentlicht werden. 9:09 am Cargill Q2 adj. Das operative Ergebnis stieg um 80 auf 1,03 Milliarden, der Umsatz um 1 Jah - resä (COMDX). Das bereinigte operative Ergebnis stieg im zweiten Quartal um 80 auf 1,03 Milliarden, verglichen mit 574 Millionen im Vorjahreszeitraum. Für die Hälfte lag das Ergebnis bei 1,86 Mrd., im Vergleich zum Vorjahreszeitraum 57,9 Mrd. Euro und 54 Mrd. für das vierte Quartal bzw. die Hälfte im Vergleich zum Vorjahreszeitraum. Das Segment Animal Nutrition amp Protein war der größte Beitrag zum bereinigten operativen Ergebnis in der Region 2. Quartal mit Ergebnisentwicklung vor allem aus dem Vorjahr Die nordamerikanische Protein-Gruppe erzielte im gesamten Produktsegment eine starke Performance. Dank der Nachfragesituation sorgte der Gesamtumsatz im Truthahngeschäft, während ein normaleres Viehangebot, eine optimierte Produktion und eine gesunde Konsumnachfrage dazu beigetragen haben, Erholung in Rindfleisch aus den letzten Jahren lowThe Ei-Geschäft weiterhin starke Verkaufszahlen in FoodserviceDie Segmente globale Geflügel-Gruppe verbesserte sich auf die letzten Jahre im zweiten Quartal, führte durch gute Ergebnisse in AsiaOrigination amp Processing Ergebnis stieg leicht gegen eine starke Vergleichsperiode, gestärkt durch die Leistung in Nord AmericaThis Jahre Rekord US-Mais und Sojakulturen mit einer robusten Nachfrage die sich aus nationalen und internationalen Wachstum in der Tierproduktion und reduziert südamerikanisch Wettbewerb für exportsWith die Versorgung Fokus auf Nordamerika getroffen wurden, erhöhte sich Cargill Bände über seine amerikanischen und kanadischen Getreideproduktion, Ölsaaten zerquetschen und Export-Anlagen mit Terminals am US-Golf und in Vancouver, British Columbia, mit KapazitätenIndustrial amp Financial Services kam zurück aus einer schwachen Vergleichsperiode, mit einem Ergebnis durch Handelsergebnisse in stärker aktive Märkte für Rohöl und raffinierte Produkte, Erdgas AND ELEKTRISCHE LEISTUNG, OZEAN-TRANSPORT UND EISEN-ORERETURNEN AUS DER VERMÖGENSMANAGEMENT AUCH AUF DIE SEGMENTE VERBESSERTE LEISTUNG. 9:08 AM ATWOOD OCEANICS PREISE UNTERSCHRIFTLICHES ÖFFENTLICHES ANGEBOT VON 13.500.000 AKTIEN SEINER GEMEINSAMEN STOCK IM PREIS IN DER ÖFFENTLICHKEIT VON 12.20SHARE (ATW). Die Gesellschaft erwartet, dass der Nettoerlös aus dem Angebot für allgemeine Unternehmenszwecke verwendet wird, einschließlich der Rückzahlung von Anleihen im Rahmen der Kreditvergabe, der FINANZIERUNG VON ZUKÜNFTIGEN KÄUFEN IHRER HERAUSGEBENEN 6,50 SENIOREN NOTES DUE 2020, ARBEITSKAPITAL UND KAPITALAUSGABEN UND ANDERWEITIG ZUR VERBESSERUNG DER LIQUIDITÄT. 09.04 DANA INC IN EINEN Mehrjahres - COMMERCIAL SALESAGREEMENT MIT Navistar International Corporation (NAV) für Antriebskomponenten für On-Highway-TRITT, Stadt-Lieferung, Bus und Berufsfahrzeuge (DAN). Durch diese Vereinbarung hat Navistar (NAV) Zugriff auf die gesamte Produktpalette von Danas aktuellen Driveline-Produkten. Darüber hinaus wird Dana die Standard-Positionsantriebe HAFT LIEFERANT ÜBER ALLE NAVISTAR TRUCK MODELS bleiben. ZUSÄTZLICH ZU DIESER VEREINBARUNG, NAVISTAR UND DANA zur gleichen Zeit mehrere PAKETE FÜR LÄNGERE GARANTIE NAVISTARS SCHOOL BUS-Plattform und deren DURASTAR Mittelklasse-Lkw-Programm gestartet. 09:04 CYTOSORBENTS EXPECTS BERICHT JA DOPPEL-DIGIT VERKAUF WACHSTUM VON APPROX 8,2 MLN IN FY16 VS. DAS 9,03 MLN KAPITAL IQ CONSENSUS (CTSO). Co rechnet mit einem Umsatzwachstum von 8,2 Millionen US-Dollar (Vj. 8,1-8,3) und verdoppelt sich von 4,0 Millionen im Jahr 2015 auf 9,03 Millionen Kunden 1,5 Millionen im vierten Quartal 2015, setzt sechs aufeinander folgenden Quartalen der Rekordverkäufe und ist sequenziell um mehr als 20 von Q3 2016.2016 Blended Brutto-Produkt-Margen, zwischen höheren Marge Direktvertrieb und niedrigeren Marge Distributor Umsatz, wird erwartet, dass mehr als 65 Überdurchschnittlich 20.000 Menschen insgesamt CytoSorb-Behandlungen gegenüber 9.000 A YEAR AGO. quotDiese Ergebnisse spiegeln die anhaltende Bedeutung und Dynamik unserer CytoSorb-Therapie in Krankenhäusern auf der ganzen Welt wider. Angesichts unserer jüngsten Partnerschafts - und Erstattungsupdates sind wir der Meinung, dass wir gut positioniert sind für ein starkes 2017.quot 9:04 am Qiagen tritt in eine strategische Zusammenarbeit mit Singulex konzentriert sich auf die Entwicklung von Companion Diagnostics (QGEN). Durch die Zusammenarbeit wird QIAGEN Zugang zu Singulexs Single Molecule Counting Immunodiagnostic-Plattform und ergänzende ZUSÄTZLICHE IMMUNOASSAY-FÄHIGKEITEN FÜR QIAGENS BESTEHENDE MOLEKULARE TESTDIENSTLEISTUNGEN FÜR DIE ENTWICKLUNG VON BERATUNGSDIAGNOSTIK. ZUSÄTZLICH IST QIAGEN ZUGRIFF AUF SINGULEXS CLIA-LIZENZIERTES LABOR. 9:04 AM COTY ZU ERHÖHEN 60 STAKE IN YOUNIQUE für ungefähr 600 MLN in CASH TRANSACTION wird erwartet, SOFORT AKCRETIVE zu seinem TOP-LINE-Wachstum, EBITDA MARGIN und FY17 EPS (COTY). Youniques Gründer und derzeitiger CEO, Derek Maxfield, und Chief Visionary Officer, Melanie Huscroft, wird auch weiterhin das Geschäft in der neuen Partnerschaft führen. Youniques Make-up und Hautpflege-Produkte werden durch seine Peer-to-Peer-E-Commerce-Plattform verkauft. Younique erwirtschaftet im Jahr 2016 einen Nettoumsatz von 400 Millionen US-Dollar. Co wird für 60 Millionen Younique einen Anteil von 600 Millionen US-Dollar an Bargeld erwerben, der durch eine Kombination von Bargeld auf den Händlern und den ver - fügbaren Schulden mit marginalen Auswirkungen auf die COTYS-VERHÄLTNISSE FINANZIERT WIRD. DIE TRANSAKTION IST FÜR KUNDENSICHERHEITSBEDINGUNGEN VORBEHALTEN UND ERWARTET, WÄHREND SEINER 3Q17 ZU SCHLIEßEN. DAS TRANSAKTION WIRD ERWARTET, SOFORT KONZEPT ZU SEINEM TOP-LINES-WACHSTUM, EBITDA-MARGIN UND FY17 ERGEBNIS. 9:02 AM SUNRUN UND NATIONAL GRID (NGG) kündigen Partnerschaft umfasst 100 Mio. Eigenkapital Engagement von National Grid in der Partnerschaft (RUN). Die Partnerschaft umfasst eine gemeinsame Marketingvereinbarung, einen gemeinschaftlichen Grid Services Pilot und eine Direktinvestition von National Grid in Sunrun Rooftop Solarsysteme. Sunrun und National Grid werden auch eine Partnerschaft zu eigenen rund 200 MW von Wohn-solar Vermögenswerte über alle Sunruns Märkte . National Grid hat dieser Partnerschaft 100 Millionen Euro Eigenkapital verpflichtet. Die Investition unterstreicht die Attraktivität des Wohnsolarbranche und unterstreicht die verschiedenen Quellen von CAPITAL SunRun KANN LEVERAGE FORTSETZUNG Wachstum zu unterstützen, EINSCHLIESSLICH BRIGHTBOXTM, SUNRUNS SOLAR-PLUS-Storage-Lösung. Die Erlöse aus den nationalen Netzen INVESTMENT IN ETWA 0,45 bis 0,55 pro Watt Neben typischen ADVANCE PREISE VON STEUER EQUITY, BACK LEVERAGE UND ANDERE Upfront Payments SUNRUNS. 9:01 AM DANA INC GEHÖRT IN MULTI-JAHRES VERKAUFVERTRAG MIT NAVISTAR (NAV) für Antriebskomponenten für Autobahn-, Stadtlieferungs-, Bus - und Berufsfahrzeuge (DAN). Durch diese Vereinbarung hat Navistar Zugriff auf die gesamte Produktpalette von Danas aktuellen Driveline-Produkten. Darüber hinaus wird Dana REMAIN DER STANDARD-POSITION DRIVESHAFT LIEFERANT ÜBER ALLE NAVISTAR TRUCK MODELS. ZUSÄTZLICH ZU DIESER VEREINBARUNG, NAVISTAR UND DANA zur gleichen Zeit mehrere PAKETE FÜR LÄNGERE GARANTIE NAVISTARS SCHOOL BUS-Plattform und deren DURASTAR Mittelklasse-Lkw-Programm gestartet. 9.01 CITY OFFICE REIT GIBT DIE UPSIZING UND PRICING dessen öffentliche Angebot von 5.000.000 Aktien der Stammaktien zu einem öffentlichen Angebotspreis von 12.40SHARE FÜR GESAMTBruttoErtrag von 62,0 Mio (CIO). Die Gesellschaft beabsichtigt, den Nettoerlös aus dem Angebot für den Erwerb von Büroimmobilien, die Rückzahlung ausstehender Beträge aus der gesicherten Kreditlinie und die allgemeinen Betriebsmittelzwecke einschließlich der Finanzierung zukünftiger Akquisitionen und Investitionen zu verwenden. 8:59 am Auf den Drähten (: WIRES). Duke Energy Renewables (DUK) hat drei Solarstrom-Projekte von SunPower (SPWR) mit insgesamt 55 Megawatt erworben. Die Standorte umfassen die 20-MW Rio Bravo I, die 20-MW Rio Bravo II und die 15-MW Wildwood Solar II Solarkraftwerke. Sie befinden sich im Kern County, Kalifornien, angrenzend an zwei bestehende Solarstandorte im Besitz von Duke Energy Renewables. Verint Systems (VRNT) erhielt einen Auftrag im Wert von mehr als 35 Millionen für mehrere Komponenten seines Cyber ​​Intelligence-Portfolios. Der Einsatz wird voraussichtlich etwa zwei Jahre dauern. Angesichts der Lieferplan, dieser Auftrag nicht auf einen wesentlichen Einfluss zu erwarten Verints Ergebnisse des vierten Quartals oder Verints Fähigkeit, seine zuvor bereitgestellten Guidance für das laufende Jahr 31. Januar endet, hat 2017.FuelCell Energy (FCEL) zu erreichen, für den Betrieb von A Megawatt-Klasse Kraft-Wärme-Brennstoffzellenanlage das sich im Santa RITA IN GEFÄNGNIS Alameda County, CALIFORNIA. FUEL TECH (FTEK) kündigten die ERHALT MEHRERE Air Pollution Control Aufträge von Kunden in den USA. Diese Preise haben einen gemeinsamen WERT 08.56 Camping World KÜNDIGT Expansionspläne in Texas mit dem Erwerb von Nordtexas RV-MAX VERKÄUFER BEGRIFFE nicht offen gelegt werden (CWH). Die geplante Übernahme von RV-Max fügt drei neue Supercenters der Dallas-Ft hinzu. Worth Markt, und als Teil unserer massiven Expansionspläne erwarten wir, zukünftige SuperCenter Standorte mit der ganzen Reihe von Camping World und Good Sam Produkte und services. quot angekündigt hinzugefügt Moody, quotWe wird Marcus Menschen, Prozess-und Produkt-Philosophie als Teil unserer Aggressive Expansion, da wir Qualitätshersteller und Marken hinzuzufügen, unsere Präsenz am Markt zu erhöhen und die Belegschaft zu wachsen. quot 8:53 am SampP Futures vs Fair Value: 0,30. Nasdaq Futures gegen den Fair Value: 0.60. (: WRAPX): Die SampP 500 Futures-Handelswohnung. Die Aktienindizes im asiatisch-pazifischen Raum endete am Dienstag mit einer überwiegend tieferen Note. Der Yen rückte gegen den Dollar in der Übernacht-Aktion, aber diese Bewegung wurde vollständig zurückverfolgt. In China stieg der PPI (5,5 Jahre über dem Erwartungswert 4,5) auf ein Fünf-Jahres-Hoch, während die Inflation auf die Konsumenten-Ebene (2,1 über dem Jahr erwartet 2,3) kühler war als erwartet. Die Nationale Entwicklungs - und Reformkommission sagte, dass die Unsicherheit im Jahr 2017 steigen wird, doch wird die Regierung die Wirtschaftsleistung weiterhin behalten. In Wirtschaftsdaten: Chinas Dezember PPI 5,5 im Vergleich zum Vorjahr (Konsens 4,5 zuletzt 3,3). Dezember CPI 0,2 Monate-over-Monat (erwartet 0,3 letzten 0,1) 2,1 Jahre gegenüber dem Vorjahr (Konsens 2,3 vorherigen 2.3) Japans Dezember Haushalts Confidence 43,1 (erwartet 41,3 zuletzt 40,9) Australias November Retail Sales 0,2 Monate-over-Monat (erwartet 0,4 Letzte 0,5) --- Aktienmärkte --- Japans Nikkei verlor 0,8, nachdem er am Montag geschlossen wurde. Fast Einzelhandel, Oki Electric, Dai-ichi Lebensversicherung, Konami, Isuzu Motoren, Hino Motors, Credit Saison und NGK Isolatoren verloren zwischen 1,8 und 2,6. Auf der Oberseite, Sony, Tokyo Electron und Dentsu erzielte Gewinne zwischen 1.2 und 2.4. Hong Kongs Hang Seng kletterte 0.8 mit Unterstützung von den meisten Bestandteilen. Immobilien-Namen wie Sino Land, New World Development, Henderson Land, Cheung Kong Property Holdings und China Resources Land zwischen 1,0 und 1,9. Telekom-Namen hinken mit China Unicom Hong Kong fallen 2.3 und China Mobile shedding 0.3. Chinas Shanghai Composite rutschte 0,3. Giti Reifen, Shanghai Material Trading, Greattown Holdings und Shanghai Diesel Motor fiel zwischen 4,4 und 5,8. Indias Sensex erweiterte 0.7 mit wachstumsempfindlichen Namen, die die Rallye führen. Adani Häfen, Tata Motoren, Tata Stahl und asiatische Farben addierten zwischen 1.5 und 3.3. Die Finanzwerte waren überwiegend höher, wobei die HDFC Bank, ICIC Bank und SBI zwischen 0,3 und 1,5 anstiegen, während die AXIS Bank 1.2 verloren hatte. Die wichtigsten europäischen Indizes handeln mit einem leichten Kursgewinn, während Spains IBEX (-0,7) unterdurchschnittlich ist. In Deutschland sagte Jörg Meuthen, Wirtschaftswissenschaftler für die rechte AFD-Partei, dass die Eurozone in zwei Währungsunionen aufgeteilt werden könnte - eine stärkere Gruppe um Deutschland herum, während eine schwächere Gruppe sich um Frankreich versammeln würde. Daran erinnern, dass Marine Le Pen, der erwartet wird, in einem engen Drei-Wege-Rennen für die französische Präsidentschaft im April zu sein, hat die Unterstützung für erhebliche Änderungen an der Struktur der Eurozone geäußert. Wirtschaftsdaten waren begrenzt: Frances November Industrieproduktion 2,2 Monate über dem Monat (erwartet 0,6 zuletzt -0,1) Schweizer Dezember Arbeitslosenquote bei 3,3 gehalten, wie erwartet --- Aktienmärkte --- UKs FTSE ist höher von 0,2 mit Bergleuten mit relativen Stärke. Anglo American, Rio Tinto, BHP Billiton, Antofagasta, and Fresnillo posted gains between 2.4 and 6.1. Consumer names have also contributed to the advance with Tesco, Morrison Supermarkets, InterContinental Hotels, Merlin Entertainments, Next, and Sainsbury adding between 1.4 and 3.9. Homebuilders Taylor Wimpey, Persimmon, and Barratt Developments are up between 1.7 and 2.7. Germanys DAX has added 0.1. Siemens has jumped 1.7 in reaction to an upgrade, while exporters are mixed. Continental holds a 2.3 gain while Volkswagen sits just below its flat line. Financials have been weak with Commerzbank and Deutsche Bank down 1.4 and 2.7, respectively. Frances CAC sits just above its flat line, looking to avoid its second consecutive decline. Recent strength in commodity prices has sent ArcelorMittal to the top of the days leaderboard with a gain of 3.0. Automakers Renault and Peugeot are up 2.8 anD 0.5, RESPECTIVELY, WHILE FINANCIALS ARE MIXED. SOCIETE GENERALE HAS ADDED 0.4 WHILE CREDIT AGRICOLE AND BNP PARIBAS ARE BOTH DOWN 0.1 AND 0.4, RESPECTIVELY. COUNTERCYCLICAL NAMES LIKE ORANGE AND VEOLIA ENVIRONNEMENT LAG, DOWN 1.6 AND 2.4, RESPECTIVELY. SPAINS IBEX TRADES LOWER BY 0.7 AMID WEAKNESS IN FINANCIALS. BANCO POPULAR, BBVA, BANKIA, BANCO SABADELL, AND CAIXABANK ARE DOWN BETWEEN 0.5 AND 2.8. 8:53 AM COOPER-STANDARD PROVIDES FY17 GUIDANCE IN SLIDE PRESENTATION ( CPS ). Co issues downside guidance for FY17 (Dec), sees FY17 (Dec) revs of 3.48-3.53 bln vs. 3.54 bln Capital IQ Consensus Estimate sees adjusted EBITDA of 12.3-12.8 sees CapEx of 165-175 mln. 8:49 am Gapping down ( SCANX ) : Gapping down In reaction to disappointing earningsguidance: HGG -51.9, (HHGregg sees fiscal Q3 sales of 453 mln vs. 564.3 mln Capital IQ Consensus Est co expects to incur a non-cash charge for asset impairment of 7-12 mln of certain locations in the quarter ended December 31, 2016), ASNA -20.1, WDFC -8.6, FRSH -7.1, (issues downside Q4 revenue guidance), NSTG -6.4, BOOT -5.3, (Boot Barn Holdings reports light prelim Q3 results ahead of ICR conf), SHOO -4.9, CRAY -4.2, (anticipates 2016 revenue to be in previously provided range believes it will be difficult to grow over 2016 in 2017 ), HALO -4.1, (guides 2017 revenue below expectations), SCVL -2.3, (sees FY17 1.36-1.38 vs 1.49 Capital IQ Consensus Estimate sees revs 1.000-1.003 bln vs 1.00 bln Capital IQ Consensus Estimate), ABMD -2.2, (offers prelim Q3 rev results, reaffirms FY17 outlook ahead of presentation at the Annual J. P. Morgan Healthcare Conference), VTR -1.2, HRC -1.1, FLDM -1, ( guides Q4 revenue below consensus ), Other news: AKER -29 (prices 1,667,000 shares of common stock at 1.20 per share, together with 833,500 five-year warrants to purchase common stock with an exercise price of 1.50)WMB -10.3 (prices 65 mln shares of common stock at 29.00 per share)ATW -5.9 (commenced an underwritten public offering of 13,500,000 shares of common stock)WPZ -4.3 (announce financial repositioning for long-term, sustainable growth Both cos announced an agreement to permanently waive payment obligations), CIO -3.3 (commences 4 mln common stock offering)MACK -1.9 (modestly pulling back following yesterdays strength)DM -1.5 (Dominion Midstream files for offering of 25,383,348 COMMON UNITS REPRESENTING LIMITED PARTNER INTERESTS BY SELLING UNITHOLDERS ), Analyst comments: WRLD -2.3 (downgraded to Underperform from Hold at Jefferies)EXPE -0.9 (initiated with a Sell at Citigroup)GS -0.8 (downgraded to Sell at CitigrouP) 8:47 AM HILL INTERNATIONAL RECEIVES A FIVE-YEAR CONTRACT WORTH APPROX. 35 MLN FROM THE SANTA CLARA VALLEY TRANSPORTATION AUTHORITY ( HIL ). Hill international will provide project management oversight and construction management services in connection with Valley Transportation Authoritys highway, roadway, pedestrianbicycle, transit and facility projects. 8:46 am Coherus BioSciences announces positive topline 24-week treatment phase 3 results for CHS-1420 in patients with psoriasis ( CHRS ) : This is a confirmatory 3-part study in patients with active, moderate to severe, chronic plaque psoriasis. Data from this study will be presented at an upcoming scientific conference. They currently anticipate filing the Biologic License Application submission in the first half of 2017. As previously reported, this study met its primary endpoint demonstrating similarity between CHS-1420 and Humira with respect to percentage of subjects achieving 75 improvement in psoriasis area and severity index at week 12. The 95 confidence intervals for the difference between treatment groups fell well within the pre-specified margin. Results from Part 2 of the study focused on maintenance of response through Week 24. At the start of Part 2, 80.3 of subjects in the CHS-1420 group and 77.5 of subjects in the Humira group achieved PASI-75. In Part 2, half of the subjects who were initially treatED WITH HUMIRA WERE SWITCHED TO CHS-1420, MODELING A CHRONIC PATIENTS TRANSITION TO A BIOSIMILAR. IN PART 2, MAINTENANCE OF PASI-75 WAS SIMILAR ACROSS THE 3 SUBSEQUENT TREATMENT GROUPS: CHS-1420 FOLLOWED BY CHS-1420, HUMIRA FOLLOWED BY CHS-1420, AND HUMIRA FOLLOWED BY HUMIRA. CHS-1420 AND HUMIRA WERE SIMILARLY WELL TOLERATED IN ALL GROUPS DURING PART 2. ANTI-DRUG ANTIBODY RESULTS ARE PRELIMINARY AT THIS TIME, BUT HAVE NOT IDENTIFIED ANY CLINICALLY SIGNIFICANT DIFFERENCES BETWEEN THE TREATMENT GROUPS. 8:45 AM KOPPERS HOLDINGS REPEATS FY16 GUIDANCE IN SLIDE PRESENTATION ( KOP ). Co repeats guidance for FY16 (Dec), sees FY16 (Dec) revs of 1.4 bln vs. 1.41 bln Capital IQ Consensus Estimate sees FY16 consolidated EBITDA of 168-172 mln. 8:45 am Gapping up ( SCANX ) : Gapping up In reaction to strong earningsguidance: PXLW 12.4, (sees Q4 revs at high end of guidance, expects to report GAAP profitability ) CUDA 8.5, MDRX 6.7, (ticking hiGHER REAFFIRMS Q4 GUIDANCE AND PROVIDES INITIAL OUTLOOK FOR 2017 ), ZBH 3.8, CMG 2.5, EXPR 1.8, OFIX 1.8, TACO 1.7, (PREANNOUNCES Q4 SALES WITH COMPS 5.5, JUST ABOVE ESTIMATES), VOXX 0.9, ZLTQ 0.7, (DISCLOSES COMMERCIAL LEADERSHIP TRANSITION, PROVIDES PRELIM Q4 RESULTS, FY17 GUIDANCE), MampA news: VRX 11.7 (divests its CeraVe, AcneFree and AMBI Skincare brands To LOreal ( LRLCY ) for 1.3 bln also to divest Dendreon for 819.9 mln ) Select metalsmining stocks trading higher: RIO 5.1, VALE 4.7, BBL 4.7, CLF 4.6, MT 4.4, FCX 4.1, X 2.9, AKS 2.3 Other news: NGNVC 44.5 (continued strength extending late surge higher yesterday), XGTI 20 (regains full compliance with all listing requirements of the Nasdaq), ILMN 14 (confirms the introduction the NovaSeq Series, a new and scalable sequencing architecture expected one day to enable a 100 genome Illumina and Bio-Rad Laboratories launch of the Illumina Bio-Rad Single-Cell Sequencing Solution), ARRY 8.1 (still checking), PTX 6.3 (continued strength), SSI 5.7 (modestly rebounding), KITE 3.5 (KITE PHARMA ENTERS INTO A STRATEGIC PARTNERSHIP WITH DAIICHI SANKYO CO FOR AXICABTAGENE CILOLEUCEL) PSTI 3.4 (ANNOUNCED THAT ITS PHASE III STUDY OF ITS PLX-PAD CELLS IN THE TREATMENT OF CRITICAL LIMB ISCHEMIA WAS CLEARED BY THE FDA EXPECTS TO BEGIN ENROLLING PATIENTS IN ITS PHASE III STUDY IN BOTH THE U. S. AND EUROPE DURING 1H17), BIO 3 (ILLUMINA AND BIO-RAD LABORATORIES LAUNCH OF THE ILLUMINA BIO-RAD SINGLE-CELL SEQUENCING SOLUTION), PBR 2.8 (PRICES 4 BLN IN GLOBAL NOTES), CNDT 2.4 (HIGHER IN AFTER HOURS AFTER CARL ICAHN AFFIRMED 9.77 ACTIVE STAKE IN THE XEROX ( XRX ) spin-off ), ZIOP 2.4 (ZIOPHARM amp Intrexon ( XON ) announce cooperative research and development agreement with the National Cancer Institute utilizing sleeping beauty system to generate T cells targeting neoantigens), FEYE 1.7 (in sympathy with CUDA), CYBR 1.1 (IN SYMPATHY WITH CUDA), Analyst comments: TIME 2.7 (upgraded to Outperform from Market Perform at Wells Fargo), ETFC 1.8 (upgraded to Buy from Neutral at Goldman ), VOD 1.7 (upgraded to Buy from Neutral at Goldman ), XRX 1.6 (upgraded to Buy from Neutral at Goldman ), BIDU 1 (upgraded to Buy from Hold at Stifel) 8:39 am EXFO amends Annual Report for fiscal 2016 after identifying a material weakness in the companys internal control over financial reporting ( EXFO ) : Subsequent to the original filing of its Annual Report on Form 20-F for fiscal 2016 on November 28, 2016, EXFO management identified a material weakness in the companys internal control over financial reporting, resulting in the improper aging of its trade accounts receivable ledger which led to an incorrect assessment of bad debt expense against a single trade account receivable. Specifically, the company did not maintain sufficient controls over the trade accounts receivable ledger, which included failure to maintain appropriate segregation of duties as well as lack of supervisory review and monitoring of journal entries recorded to the trade accounts receivable ledger. EXFO management determined that the identified control deficiencies could have resulted in a material misstatement of the aforementioned account balances or disclosures that would not have been prevented or detected, and therefore these control deficiencies represent a material weakness in internal control over financial reporting. Considering the identified material weakness, the companys Chief Executive Officer and the Chief Financial Officer have concluded that internal controls over financial reporting were not effective as of August 31, 2016.Although EXFO management determined that the errors were not material to the previously issued consolidated financial statements and disclosures in its Annual Report on Form 20-F for the year ended August 31, 2016, management revised its previously issued consolidated financial statements to reflect the correction oF THE BAD DEBT EXPENSES IN THE PROPER PERIODS. THE REVISIONS DO NOT CONSTITUTE A RESTATEMENT OF PRIOR YEARS FINANCIAL STATEMENTS. THE IMPACT OF THE REVISION ON EXFOS CONSOLIDATED FINANCIAL STATEMENTS AS AT AND FOR THE YEAR ENDED AUGUST 31, 2016 ARE NON-CASH AND THEREFORE DO NOT AFFECT THE COMPANYS STATEMENTS OF CASH FLOWS FOR ANY OF THE PRIOR PERIODS AND DO NOT AFFECT THE COMPANYS CONSOLIDATED STATEMENTS OF EARNINGS FOR THE YEAR ENDED AUGUST 31, 2016. THE IMPACT ON NET EARNINGS AMOUNT TO A REDUCTION OF US441,000 AND US527,000 FOR THE FISCAL YEARS ENDED AUGUST 31, 2015 AND 2014, RESPECTIVELY. 8:38 AM LEAR PROVIDES FY17 GUIDANCE IN SLIDE PRESENTATION ( LEA ). Co issues upside guidance for FY17 (Dec), sees FY17 (Dec) revs of 19.5 bln vs. 19.26 bln Capital IQ Consensus Estimate sees core operating earnings of 1.6 billion sees FY17 total vehicle unit production of 91.7 mln vs 90.9 mln in FY16 8:38 am EP Energy files for 43,786,694 common stock offering by selling stockholders ( EPE ). 8:34 am Lamb Weston beats by 0.07, beats on revs guides FY17 EPS above consensus, raises sales outlook ( LW ). Reports Q2 (Nov) earnings of 0.63 per share, excluding non-recurring items, 0.07 better than the Capital IQ Consensus of 0.56 revenues rose 6.8 yearyear to 790.7 mln vs the 772.1 mln two analyst estimate. Volume increased 4 percentage points as productivity programs and strong manufacturing plant performance stretched available capacity, allowing the Company to meet demand growth in both North America and international markets. Pricemix increased 3 percentage points due to pricing actions and favorable product and customer mix. CO ISSUES upside guidance for FY17, sees EPS of 2.20-2.28, excluding non-recurring items, vs. 2.11 Capital IQ Consensus Estimate sees net sales up mid-single digits vs. prior guidance for up low single digits. Co expects Adjusted EBITDA including unconsolidated joint ventures to grow at a mid-teens rate, up from a previous estimate of a high single digit increase, reflecting solid sales growth and savings from supply chain efficiencies, partially offset by lower contribution from equity method investment earnings. Potato costs are expected to remain essentially flat. 8:33 am Dexcom sees Q4 revs roughly in line with estimates sees FY17 revs below consensus ( DXCM ). Co issues in-line guidance for Q4 (Dec), sees Q4 (Dec) revs of 168 mln vs. 167.15 mln Capital IQ Consensus Estimate. quot2016 was a RECORD YEAR FOR DEXCOM. WE ESTIMATE THAT 80,000 TO 90,000 NEW PATIENTS ADOPTED DEXCOM CONTINUOUS GLUCOSE MONITORING WORLDWIDE AND WE ENDED THE YEAR WITH APPROXIMATELY 200,000 PATIENTS GLOBALLY, UP FROM APPROXIMATELY 140,000 AT THE END OF 2015.quotCo issues downside guidance for FY17 (Dec), sees FY17 (Dec) revs of 710-740 mln vs. 750.92 mln Capital IQ Consensus Estimate. At the end of 2017, the company is targeting a patient base of 270,000 worldwide and continues to estimate that patients outside of the United States will be approximately 20 to 25 of its global patient base. 8:33 am Sarepta Therapeutics discloses entry into two agreements with the Nationwide Childrens Hospital ( SRPT ). The co has entered an exclusive license agreement with Nationwide Childrens Hospital, for their Galgt2 gene therapy program developed by researcher Dr. Paul Martin, Ph. D. The experimental program explores the potential surrogate gene therapy approach to Duchenne muscular dystrophy. quotOur goal is to have this program in the clinic during 2017 and begin to evaluate a therapy that has the potential to treat patients of all ages and disease severity. quotThe co also has entered a research and option agreement with Nationwide Childrens Hospital on their microdystrophin gene therapy program. Dr. Jerry Mendell, M. D. and Dr. Louise Rodino-Klapac, Ph. D. are the lead principal investigators of thE PROGRAM. THE INITIAL TRIAL, EXPECTED TO GO INTO PHASE 12A TRIAL IN LATE 2017, WILL BE CONDUCTED AT NATIONWIDE CHILDRENS. PARENT PROJECT MUSCULAR DYSTROPHY HAS COMMITTED 2.2 MILLION DOLLARS TO THE TRIAL, WITH SUPPORT FROM ADDITIONAL DUCHENNE FOUNDATIONS AND FAMILIES. SAREPTA HAS COMMITTED TO THE TRIAL THROUGH A SEPARATE RESEARCH AGREEMENT WITH NATIONWIDE CHILDRENS, AND HAS AN EXCLUSIVE OPTION TO LICENSE THE PROGRAM. PPMDS GRANT PROVIDED INCENTIVE FOR SAREPTA TO HELP EXPAND AND ACCELERATE THIS OPPORTUNITY. 8:33 AM CORVUS PHARMACEUTICALS ANNOUNCES THAT THE PROTOCOL-PREDEFINED CRITERIA FOR EXPANSION HAS BEEN REACHED FOR THE COHORT OF PATIENTS WITH RENAL CELL CARCINOMA TREATED WITH SINGLE-AGENT CPI-444 IN THE COMPANYS ONGOING PHASE 11B STUDY ( CRVS ). Co announced that the protocol-predefined criteria for expansion has been reached for the cohort of patients with renal cell carcinoma treated with single-agent CPI-444 in the Companys ongoing Phase 11b study. The size of that cohort will be increased from 14 to 26 patients. The Phase 11b study is evaluating CPI-444, a selective and potent inhibitor of the adenosine A2A receptor, as a single agent and in combination with Genentechs Tecentriq (atezolizumab).The first part of the trial (dose-selection) was completed in October 2016, and enrollment of patients in disease-specific cohorts in the second part of the trial is currently underway. Could potentially initiate a registration trial before the end of 2017. That study would evaluate CPI-444 in late-stage renal cancer patienTS, FOR WHOM CURRENT TREATMENT OPTIONS ARE VERY LIMITED. TO DATE, CPI-444 HAS BEEN WELL TOLERATED WHEN GIVEN ORALLY TWICE DAILY. HAS ALSO SEEN PROMISING EVIDENCE OF SINGLE-AGENT ACTIVITY IN PATIENTS IN OTHER DISEASE-SPECIFIC COHORTS, INCLUDING LUNG CANCER AND MELANOMA. THE PRIMARY ENDPOINTS OF THE STUDY ARE RESPONSE RATE AND DURATION OF CLINICAL BENEFIT. BASED ON BIOMARKER ANALYSES SHOWING SUSTAINED, COMPLETE BLOCKADE OF THE ADENOSINE A2A RECEPTOR IN PERIPHERAL BLOOD LYMPHOCYTES, AND EVIDENCE OF IMMUNE ACTIVATION IN CIRCULATING LYMPHOCYTES, AN OPTIMUM SINGLE AGENT AND COMBINATION DOSE OF 100 MG TWICE A DAY FOR 28 DAYS WAS SELECTED FOR THE SECOND PART OF THE STUDY. 8:32 AM RED ROBIN GOURMET FOLLOW UP - CO ISSUES DOWNSIDE GUIDANCE AHEAD OF ICR CONFERENCE ( RRGB ). Co issues downside guidance for Q4 (Dec), sees Q4 (Dec) revs of 290.80 mln vs. 299.52 mln Capital IQ Consensus EstimatePARABLE RESTAURANT REVENUE DECREASE OF 4.5 COMPARABLE GUEST COUNT DECREASE OF 2.9 quotThe initiatives we put in place last fall -- our new 6.99 every day value items, improved SPEED TO TABLE, AND THE LETS BURGER AD CAMPAIGN -- ARE HELPING US GROW MARKET SHARE AGAIN, quot said DENNY MARIE POST, RED ROBIN GOURMET BURGERS, INC. S CHIEF EXECUTIVE OFFICER. quotWe outperformed casual dining industry traffic trends by 243 basis points in Q4 and saw further improvement in guest service ratings. Continuing this momentum and layering in off-premise initiatives later this year will help us grow in 2017 and beyond. quot 8:31 am Resonant CEO Terry Lingren will retire George B. Holmes, the cos President and Chief Commercial Officer, has been named his successor effective immediately ( RESN ). 8:31 am Mellanox Tech announces that Spectrum Ethernet switches amp ConnectX 4 100Gbs Ethernet adapters have been selected by Baidu ( BIDU ) for Baidus Machine Learning platforms terms not disclosed ( MLNX ). 8:31 am SampP futures vs fair value: flat. Nasdaq futures vs fair value: 0.40. (:WRAPX) : The stock market is poised for a flat open as the SampP 500 futures trade at fair value. In corporate news, many companies have issued guidance ahead of conferences today. Several retailers and restaurants have issued cautious guidance, including Chipotle Mexican Grill (CMG 396.00, 0.94), Papa Murphys (FRSH 4.25, 0.00), POPEYES LOUISIANA KITCHEN (PLKI 59.06, 0.00), KONA GRILL (KONA 11.75, 0.00), SHOE CARNIVAL (SCVL 25.49, 0.00), BOOT BARN HOLDINGS (BOOT 11.50, -0.64), AND EXPRESS (EXPR 10.50, 0.19), AMONG OTHERS. ON THE EARNINGS FRONT, BARRACUDA NETWORKS (CUDA 25.80, 2.03) IS HIGHER BY 8.5 IN PRE-MARKET TRADE AFTER BEATING TOP AND BOTTOM LINE ESTIMATES AND ISSUING IN-LINE GUIDANCE. WD-40 (WDFC 110.30, -7.00) IS LOWER BY 6.0 AFTER MISSING ON THE TOP AND BOTTOM LINES AND REAFFIRMING GUIDANCE. U. S. TREASURIES REMAIN UNDER PRESSURE WITH THE 10-YR YIELD UP TWO BASIS POINTS TO 2.39. 8:30 AM LABORATORY CORP TO ACQUIRE ASSETS OF MOUNT SINAI HEALTH SYSTEM CLINICAL OUTREACH LABORATORIES TERMS NOT DISCLOSED ( LH ). Mount Sinai will continue to provide laboratory testing for patients registered at its hospitals and ambulatory facilities as inpatients or outpatients, as well as laboratory testing services for physiCIANS IN THEIR PROFESSIONAL PRACTICES IN THE AREAS OF ANATOMIC PATHOLOGY, MOLECULAR PATHOLOGY AND GENETICS. LABCORP WILL OFFER CLINICAL PATHOLOGY TESTING, INCLUDING CYTOLOGY AND CYTOLOGY-RELATED MOLECULAR TESTING. SEVEN PATIENT SERVICE CENTERS CURRENTLY OPERATED BY MOUNT SINAI WILL BE ADDED TO LABCORPS EXISTING NETWORK OF 120 PATIENT SERVICE CENTERS IN THE METROPOLITAN NEW YORK CITY AREA. THE PARTIES ARE ALSO VIGOROUSLY EXPLORING OPPORTUNITIES TO COLLABORATE ON PROJECTS INVOLVING COMPANION DIAGNOSTICS, CLINICAL TRIALS AND MEDICAL EDUCATION. THE TRANSACTION, WHICH HAS ALREADY RECEIVED CLEARANCE UNDER THE HART-SCOTT-RODINO ANTITRUST IMPROVEMENTS ACT OF 1976, IS EXPECTED TO CLOSE IN THE FIRST QUARTER OF 2017 8:30 AM PERRIGO TO CHANGE REPORTING SEGMENTS BEGINNING IN Q4 - WILL HAVE NO IMPACT ON HISTORICAL RESULTS ( PRGO ) : Co changes its reporting segments to better align with its organizational structure. Beginning with the Q4, its new reporting segments are: Consumer Healthcare Americas -- Comprises the legacy US, Mexico and Canada consumer healthcare business (OTC, contract, infant formula and animal health categories). Consumer Healthcare International -- Comprises the legacy Branded Consumer Healthcare segment and now includes its consumer focused businesses in the UK Australia and Israel, which were previously reported in the legacy Consumer Healthcare segment. Prescription Pharmaceuticals -- Comprises the legacy US Prescription Pharmaceuticals business. Specialty Sciences -- Will continue to comprise royalties from Tysabri. Other -- Will continue to comprise the legacy Active Pharmaceutical Ingredients (:API) business. 8:29 am On The Wires (:WIRES). Lianluo Smart Limited (LLIT) announced that it has received the design patent certificate for the DHR 998 Plus Wearable Sleep Apnea Syndrome Diagnostic Watch, which is a main product under the business of the Companys medical wearable device sector. Natera (NTRA) announced the termination of a distribution agreement with Bioreference Laboratories. With the ending of the distribution agreement, Natera intends to promote Panorama directly to clinicians, who previously ordered this test through Bio-Reference. Natera also plans to promote its Horizon carrier screen test to these clinicians, which it had not done previously. Lionsgate (LGF. A, LGF. B) announced that it has invested in leading eSports franchise Immortals. Merck (MKGAY) announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and industry leading technological expertise. Majesco Entertainment (COOL) changes name to PolarityTE, Inc. effective January 11 ticker unchanged. Wix (WIX) announced its integration with Square to give Wix merchants and entrepreneurs in North America a new way to accept online and in-person credit card payments. RedHill Biopharma (RDHL) announced the first group of subjects have been dosed in a single-dose three-way crossover pharmacokinetic study with RHB-105 versus the active comparators in the confirmatory Phase III STUDY AND IN A FOOD-EFFECT STUDY WITH RHB-105 IN HEALTHY VOLUNTEERS. THE CONFIRMATORY PHASE III STUDY WITH RHB-105 FOR H. PYLORI INFECTION IS PLANNED TO BE INITIATED, SUBJECT TO REGULATORY APPROVALS AND COMPLETION OF THE SUPPORTIVE PHARMACOKINETIC PROGRAM, BY APRIL OF THIS YEAR. SUBJECT TO A SUCCESSFUL OUTCOME, THE CONFIRMATORY PHASE III STUDY AND THE SUPPORTIVE PHARMACOKINETIC PROGRAM ARE EXPECTED TO COMPLETE THE PACKAGE REQUIRED FOR A U. S. NDA FOR RHB-105.INVIVO THERAPEUTICS (NVIV) ANNOUNCED THAT RHODE ISLAND HOSPITAL IN PROVIDENCE, RI HAS BEEN ADDED AS A CLINICAL SITE FOR THE INSPIRE STUDY: INVIVO STUDY OF PROBABLE BENEFIT OF THE NEURO-SPINAL SCAFFOLD FOR SAFETY AND NEUROLOGIC RECOVERY IN SUBJECTS WITH COMPLETE THORACIC AIS A SPINAL CORD INJURY. 8:22 AM VARIAN MEDICAL BOARD APPROVES SEPARATION OF THE COMPANYS IMAGING COMPONENTS BUSINESS ( VAR ) : The separation is intended to be executed via a tax-free distribution to Varian stockholders of common stock in Varex Imaging Corporation, a new stand-alone public company that will hold the Imaging Components business. The distribution is expected to be completed ON JANUARY 28, 2017, SUBJECT TO THE SATISFACTION OR WAIVER OF THE CONDITIONS TO THE COMPLETION OF THE DISTRIBUTION DESCRIBED IN THE PRELIMINARY INFORMATION STATEMENT FILED AS AN EXHIBIT TO VAREXS REGISTRATION STATEMENT ON FORM 10 FILED WITH THE U. S. SECURITIES AND EXCHANGE COMMISSION. IN THE DISTRIBUTION, VARIAN STOCKHOLDERS WOULD RECEIVE 0.4 SHARE OF VAREX COMMON STOCK FOR EVERY ONE SHARE OF VARIAN COMMON STOCK HELD AS OF JANUARY 20, 2017, THE RECORD DATE FOR THE DISTRIBUTION. NO FRACTIONAL SHARES OF VAREX WILL BE ISSUED. VAREX SHARES ARE EXPECTED TO BEGIN quotregular wayquot trading on Monday, January 30, 2017 on Nasdaq under the ticker symbol quotVREXquot. Varian will continue to trade on the New York Stock Exchange under the ticker symbol quotVARquot. 8:19 am Novo Nordisk announces the EC granted marketing authorization for Fiasp for the treatment of diabetes in adults ( NVO ). The co expects to launch Fiasp in the first European countries in the first half of 2017. 8:16 am Icahn Enterprises commences 900 mln private placement of Senior Notes due 2022 and Senior Notes due 2024 and, separately, announces 600 mln rights offering ( IEP ). The proceeds from the Notes offering, together with cash and cash equivalents at Icahn Enterprises and cash received from redemptions from investment funds, will be used to redeem all of the Issuers existing 3.500 Senior Notes due 2017 and pay related fees and expenses. The purposes of the rights offering are: (i) to enhance IcahN ENTERPRISES DEPOSITARY UNIT HOLDER EQUITY (II) TO ENDEAVOR TO IMPROVE ICAHN ENTERPRISES CREDIT RATINGS AND (III) TO RAISE EQUITY CAPITAL TO BE USED FOR GENERAL PARTNERSHIP PURPOSES. PURSUANT TO THE RIGHTS OFFERING, ICAHN ENTERPRISES WILL DISTRIBUTE FREELY-TRADABLE RIGHTS PRO RATA TO HOLDERS OF RECORD OF ICAHN ENTERPRISES DEPOSITARY UNITS AS OF THE CLOSE OF BUSINESS ON THE RECORD DATE TO BE ESTABLISHED FOR THE RIGHTS OFFERING. CARL C. ICAHN, WHO BENEFICIALLY OWNS 89.89 OF THE COMPANYS OUTSTANDING DEPOSITARY UNITS, HAS INFORMED THE COMPANY THAT CERTAIN OF HIS AFFILIATES INTEND TO EXERCISE FULLY ALL BASIC SUBSCRIPTION RIGHTS AND OVER-SUBSCRIPTION RIGHTS ALLOCATED TO THEM IN THE RIGHTS OFFERING. 8:13 AM NATERA TERMINATES A DISTRIBUTION AGREEMENT WITH BIO-REFERENCE LABORATORIES INTENDS TO PROMOTE PANORAMA DIRECTLY TO CLINICIANS, WHO PREVIOUSLY ORDERED THIS TEST THROUGH BIO-REFERENCE ( NTRA ). Co also plans to promote its Horizon carrier screen test to these clinicians, which it had not done previously. 8:11 am CAS Medical offers prelim Q4 revs results, discusses FY17 outlook ( CASM ) : Co sees Q4 revs 5.5 mln vs 5.59 mln two analyst estimate. A record 82 FORE-SIGHT cerebral oximeters were shipped in the fourth quarter to new and existing customers in the U. S. Net of returns, 45 monitors were shipped in the U. S. bringing the installed base of U. S. monitors to 1,120 units as of December 31, 2016, up from 914 monitors as of December 31, 2015. Net 43 monitors were shipped to international customers in the fourth quarter. quotOur expectations for 2017 include a 20 increase in disposable FORE-SIGHT sensor sales and a 20 increase in the U. S. monitor installed base, coming from gains in market share and from market expansion for cerebral oximetry monitoring. We expect growth to accelerate in the second half of 2017, driven by the expansion and maturation of our U. S. salesforce. We expect total FORE-SIGHT sales growth for 2017 in the mid-teens. quot 8:08 am SampP futures vs fair value: 1.00. Nasdaq futures vs fair value: 2.30. (:WRAPX) : Equity futures are flat ahead of Tuesdays open with the SampP 500 futures trading one point above fair value. Global markets are mixed with Asia closing on a mostly lower note while European indices hold modest gains. Crude oil spent most of the overnight session near its flat line and remains at the same level this morning. The commodity is modestly higher, up 0.3 at 52.11bbl. After an upbeat start to the week, U. S. Treasuries are under modest selling pressure early this morning. The 10-yr yield is higher by two basis points at 2.39. Todays economic data will be limited to November Job Openings (:JOLTS) and November Wholesale Inventories (Briefing consensus 0.9). Both reports will be released at 10:00 am ET. In U. S. corporate news of note: Chipotle Mexican Grill (CMG 382.00, -13.06): -3.3 after issuing downside guidance. Barracuda Networks (CUDA 26.00, 2.23): 9.8 after beating on revenues and issuing in-line guidance. Williams Companies (WMB 28.83, -3.10): -9.7 after the stock was downgraded to Hold from Buy at Jefferies. Illumina (ILMN 161.00, 19.46): 13.8 after issuing above-consensus revenue guidance for the fourth quarter. The stock was upgraded to Buy from Neutral at Bank of AmericaMerrill Lynch. Reviewing overnight developments: Equity indices in the Asia-Pacific region ended Tuesday on a mostly lower note. Japans Nikkei -0.8, Hong Kongs Hang Seng 0.8, Chinas Shanghai Composite -0.3, Indias Sensex 0.7.In economic data: Chinas December PPI 5.5 year-over-year (consensus 4.5 last 3.3). December CPI 0.2 month-over-month (expected 0.3 last 0.1) 2.1 year-over-year (consensus 2.3 previous 2.3) Japans December Household Confidence 43.1 (expected 41.3 last 40.9) Australias November Retail Sales 0.2 month-over-month (expected 0.4 last 0.5) In news:In China, December PPI (5.5 year-over-year expected 4.5) climbed to a five-year high while inflation on the consumer level (2.1 year-over-year expected 2.3) was cooler than expected. The National Development and Reform Commission said that uncertainty will be on the rise in 2017, but the government will continue keeping tabs on economic performance. Major European indices trade with slim gains while SPAINS IBEX UNDERPERFORMS. UKS FTSE 0.4, GERMANYS DAX 0.2, FRANCES CAC 0.1, SPAINS IBEX -0.7.IN ECONOMIC DATA:FRANCES NOVEMBER INDUSTRIAL PRODUCTION 2.2 MONTH-OVER-MONTH (EXPECTED 0.6 LAST -0.1) SWISS DECEMBER UNEMPLOYMENT RATE HELD AT 3.3, AS EXPECTEDIN NEWS:IN GERMANY, JORG MEUTHEN, WHO IS THE ECONOMIST FOR THE RIGHT-WING AFD PARTY, SAID THE EUROZONE COULD BE SPLIT INTO TWO SEPARATE CURRENCY UNIONS-A STRONGER ONE CLUSTERED AROUND GERMANY WHILE A WEAKER ONE WOULD BE CLUSTERED AROUND FRANCE. RECALL THAT MARINE LE PEN, WHO IS EXPECTED TO BE IN A TIGHT THREE-WAY RACE FOR FRENCH PRESIDENCY IN APRIL, HAS VOICED SUPPORT FOR SIGNIFICANT CHANGES TO THE STRUCTURE OF THE EUROZONE. 8:08 AM GAIN CAPITAL REPORTS OPERATING METRICS FOR DECEMBER 2016 OTC ADV OF 8.6 BLN, -33.4 YY, ACTIVE OTC ACCOUNTS OF 129,036, -12.2 YY, FUTURES AVERAGE DAILY CONTRACTS OF 26,160, -21.2 YY ( GCAP ) : Institutional Segment Metrics ECN average daily volume of 9.2 billion, 36.0 YYECN volume of 202.1 billion, 36.0 YY Swap Dealer average daily volume of 3.2 billion, 20.3 YY Swap Dealer volume of 70.0 billion, 20.3YY 8:08 am GenMark Diagnostics sees Q4 rev in-line ( GNMK ). Sees Q4 revs 13 tO 14.9 MLN VS 14.80 MLN CAPITAL IQ CONSENSUS. THE COMPANY ALSO ANNOUNCED THAT IT FINISHED THE YEAR WITH MORE THAN 55 CUSTOMER AGREEMENTS IN PLACE TOTALING OVER 85 EPLEX INSTRUMENTS. quotFourth quarter revenue was in line with our expectations, despite a slow start to the flu season. Furthermore, we are very pleased with the increasing customer interest in our ePlex sample-to-answer system, particularly following our submissions to FDA last month. We finished the year with more than 55 agreements for over 85 ePlex instruments, many of which have already been installed in end-user sites. Customer feedback has been very positive, especially on ease of use and workflow. quotComplete 2016 fourth quarter and full year financial results will be announced during the Companys fourth quarter earnings call. At that time, the Company also anticipates providing 2017 financial guidance. 8:06 am Cognex announces they acquired Chiaro Technologies amp Webscan terms not disclosed ( CGNX ) : Co announces the recent acquisition of two technology companies in the fast-growing areas of 3D vision and industrial ID. On Nov 30, 2016, Cognex acquired Chiaro Technologies, maker of an innovative 3D machine vision sensor called Cloudburst. Chiaros Cloudburst sensor offers hiGH-SPEED, REAL-TIME 3D IMAGE STREAMING THAT IS USEFUL IN APPLICATIONS WHERE SPEED IS MORE IMPORTANT THAN CAPTURING A HIGH RESOLUTION IMAGE. ON DEC 9, 2016, COGNEX ALSO ACQUIRED WEBSCAN, A LEADER IN BARCODE VERIFICATION SOLUTIONS. WEBSCANS SOLUTION ENABLES MANUFACTURERS TO ENSURE THAT BARCODES MARKED ON PACKAGES, PARTS AND COMPONENTS ARE APPLIED ACCURATELY BEFORE ITEMS ARE SHIPPED, AND VERIFIES THAT CODES COMPLY WITH INDUSTRY STANDARDS. quotThe Cloudburst sensor enables Cognex to address a wider range of applications and price points in the fast-growing 3D vision market. And the combination of Webscans verification software with our rugged and flexible DataMan product line will enABLE COGNEX TO PROVIDE THE INDUSTRYS BROADEST RANGE OF HIGH-PERFORMANCE AND EASY-TO-USE VERIFICATION SOLUTIONS. quot 8:06 am Axcelis Tech announces shipments in 4Q16 of the Purion XE high energy implanter to multiple customers in the Asia Pacific Region guides Q4 revs on the high end of its guidance, and EPS above guidance ( ACLS ). quotWe expect fourth quarter revenue to be on the high end of our guidance, and EPS above guidance primarily driven by strong gross margin performance. We also continue to anticipate increased revenue in the first quarter of 2017.quotquotThese shipments represent the leading edge of expected strong capital investment in the memory sector in 2017. Memory growth will be driven by a strong Internet of Things market and the overall Connected World. quot 8:05 am Sangamo BioSci presents improvements to its technology platform for engineering highly specific zinc finger nucleases for therapeutic genome editing applications ( SGMO ). The data demonstrate genome editing of therapeutic gene targets in clinically relevant cell types, including high levels of targeted modification (80) of the BCL11A enhancer in hematopoietic stem and progenitor cells at clinical scale with no significant off-target activity. 8:05 am Alaska Air reports December operational results, traffic 5.6 ( ALK ). On a combined basis, Air Group reported a 5.6 percent increase in traffic on a 5.0 percent increase in capacity compared to December 2015. Load factor increased 0.5 points to 83.1 percent. These statistics include flighTS OPERATED BY ALASKA, VIRGIN AMERICA, HORIZON, AND THOSE UNDER THIRD-PARTY CAPACITY PURCHASE AGREEMENTS. 8:05 AM TORCHLIGHT ENERGY RESOURCES ANNOUNCES THAT DRILLING OF THE FLYING B RANCH 2 VERTICAL WELL WAS COMPLETED TO A TOTAL DEPTH OF 6,550 FEET PRELIM ANALYSIS RESULTED IN THE IDENTIFICATION OF 400 FEET OF CONTINUOUS PAY COMPRISED OF 80 FEET OF DEAN AND 320 FEET OF WOLFCAMP AampB FORMATIONS ( TRCH ). Torchlight has planned a completion procedure to commence on January 18th with a scheduled fracing of the well which will target the 400 of pay identified in the Wolfcamp and Dean formations. The Company plans to perform a significantly larger multiple-stage frac than previously employed where they will utilize 600,000 lbs. of sand pumped at a fluid rate of 75-100 barrels per minute. Torchlight expects the well to be a vertical producer providing further confirmation for economic horizontal development potential. 8:04 am Hill-Rom to acquire Mortara Instrument for 330 mln in cash ( HRC ) : Mortara Instrument is a privately held company in diagnostic cardiology and patient monitoring solutions, technologies, and devices. Hill-Rom anticipates the structure of the acquisition will allow the company tO QUALIFY FOR A SIGNIFICANT TAX BENEFIT, WHICH AT A NET PRESENT VALUE OF APPROXIMATELY 40 MILLION REDUCES THE EFFECTIVE PURCHASE PRICE TO APPROXIMATELY 290 MILLION. HILL-ROMS ACQUISITION OF MORTARA IS EXPECTED TO ACCELERATE HILL-ROMS REVENUE GROWTH AND BE ACCRETIVE TO BOTH GROSS AND OPERATING MARGINS. EXCLUDING SPECIAL ITEMS, THE TRANSACTION IS EXPECTED TO BE MODESTLY ACCRETIVE TO HILL-ROMS FISCAL 2017 ADJUSTED EARNINGS PER SHARE. THE COMPANY PLANS TO REALIZE ANNUAL OPERATIONAL SYNERGIES OF AT LEAST 10 MILLION, AND EXPECTS THE TRANSACTION TO SUPPORT ITS MARGIN EXPANSION OBJECTIVES AND DRIVE GREATER ACCRETION TO ADJUSTED EARNINGS PER DILUTED SHARE BEYOND 2017. THE COMPANY WILL UPDATE ITS FISCAL 2017 FINANCIAL GUIDANCE AFTER THE TRANSACTION CLOSES. HILL-ROM INTENDS TO FINANCE THE TRANSACTION THROUGH A COMBINATION OF CASH ON HAND AND BORROWINGS UNDER EXISTING CREDIT FACILITIES. THE TRANSACTION IS EXPECTED TO CLOSE IN HILL-ROMS FISCAL SECOND QUARTER OF 2017. 8:04 AM PIONEER POWER SOLUTIONS SEES FY17 EPS ABOVE SINGLE EST REVS IN LINE WITH SINGLE EST ( PPSI ). Co issues guidance for FY17 (Dec), sees EPS of 0.83-0.91 vs. 0.52 single analyst estimate sees FY17 (Dec) revs of 120-127 mln vs. 124.80 MLN SINGLE ANALYST ESTIMATE. quotThis outlook represents continued margin expansion and further improvement in profitability, as we continue to benefit from the operational improvements we have made and continue to make. We remain focused on higher margin opportunities, resulting in targeted growth. We see continued strong demand for our solutions, as evidenced by our solid backlog of 39.6 million as of December 31, 2016, up from 28.7 million in backlog at December 31, 2015. In particular, we are expanding our presence in the areas of microgrids, distributed generation, on-site generation service and data center solutions. The continued bottom-line improvements are due to our ability to extract operational LEVERAGE FROM OUR BUSINESS, AND WE ARE CONFIDENT WE CAN FURTHER EXPAND PROFITABILITY AND CASH GENERATION AS WE SCALE THE BUSINESS. quot 8:03 am ZIOPHARM amp Intrexon ( XON ) announce cooperative research and development agreement with the National Cancer Institute utilizing sleeping beauty system to generate T cells targeting neoantigens ( ZIOP ) : quotTreating liquid tumors with chimeric antigen receptors has yielded extraordinary results with genetically engineered T cells and the next stage in the evolution of this immunotherapy is the expression of T-cell receptors to target solid tumors, quot said Laurence Cooper, MD, PhD, Chief Executive Officer of ZIOPHARM. quotThrough use of the scalable non-viral Sleeping Beauty platform to express an array of TCRs that recognize neoantigens within each patients tumor, we can customize T-cell therapies and enhance their function through cytokines and switches. quot 8:03 am Immunomedics stockholder venBio responds to recent Board nominees by the co and touts its 4 candidates to the Board ( IMMU ) : venBio Select Advisor, which owns a 9 stake in IMMU and is its largest stockholder, responds to the announcement by Immunomedics of new nominees for the Board of Directors as well as leadership adjustments. quotWe strongly believe that this announcement from Immunomedics is too little, too late, and indicates that they do not understand the severity OF OUR CONCERNS, WHICH WE BELIEVE ARE SHARED BY MANY STOCKHOLDERS. DESPITE THE COMPANYS RECENT ACTIONS, IT HAS NOT ASSEMBLED THE EXPERTISE NEEDED TO OVERSEE ITS MAIN ASSET, IMMU-132, AND THE CRITICAL PERIOD AHEAD FOR IT -- NAMELY THE LICENSING AND PARTNERING PERIOD. WE ARE ALSO STILL CONCERNED ABOUT THE LONG-TERM FUTURE OF THE COMPANY. quotFirm says quotImmunomedics has been mismanaged for years. and the Companys announced plan today is simply an example of more of the same mismanagement. While we welcome the long-overdue announcement that the Company will begin a search for a new CEO, we believe it is imperative that this search and succession be led by a well-qualified independent Board. The nominees put forth today by Immunomedics fall short of our slate. quotquotWe believe that investors should exercise their opportunity to voice their frustration at the strategic missteps of the Companys leadership by voting on thE GOLD PROXY CARD WHEN THEY RECEIVE IT. quot 8:03 am Hill-Rom expects Q4 EPS to be at the lower end of previous guidance range of 0.75-0.77, Capital IQ consensus 0.76 Sees revenue of approx 637 mln, Capital IQ consensus 656 mln ( HRC ). Hill-Rom expects adjusted earnings to be at the lower end of its previously-issued guidance of 0.75 to 0.77 per diluted share. Hill-Rom is also reaffirming its 2017 full-year adjusted earnings guidance of 3.74 to 3.82 per diluted share, as provided in its fourth quarter 2016 earnings announcement. For the fiscal first quarter, worldwide revenue of 637 million (Capital IQ consensus 656 mln) declined 4 percent versus the first quarter last year. In addition TO A DIFFICULT COMPARISON TO THE PRIOR-YEAR PERIOD, FIRST QUARTER REVENUE GROWTH WAS IMPACTED BY THE TIMING OF CERTAIN INTERNATIONAL AND U. S. DISTRIBUTOR ORDERS, AND LOWER REVENUE FROM BUSINESSES THE COMPANY DIVESTED DURING THE MOST RECENT QUARTER OR PLANS TO DIVEST IN 2017. 8:02 AM QUICKLOGIC SEES Q4 REVS AT MID-POINT OF GUIDANCE ( QUIK ). Co sees Q4 revs 2.9 mln (midpoint of guidance range) vs 2.90 mln two analyst estimate. This revenue comprised approximately 1.6 million of new product revenue and 1.3 million of mature product revenue. The Company ended the fourth quarter with a higher than anticipated cash balance of approximately 14.9 million. quotIm very pleased with the strategic progress we maDE DURING THE FOURTH QUARTER AND THE ACCELERATED MOMENTUM WE GATHERED DURING THE 2017 CONSUMER ELECTRONICS SHOW IN LAS VEGAS THIS PAST WEEK. GIVEN THIS PROGRESS AND THE MOMENTUM, I BELIEVE WE ARE ON TRACK TO REALIZE THE STRATEGIC OBJECTIVES WEVE PREVIOUSLY OUTLINED FOR 2017.quot 8:01 am Orthofix sees Q4 rev above consensus FY17 rev below consensus, EBITDA margin consistent with FY16 ( OFIX ). Sees Q4 revs 109 mln vs 104.73 mln Capital IQ Consensus these preliminary results represent reported sales growth of 3.7 and constant currency sales growth of 4.2 over the fourth quarter 2015. Sees FY17 rev 407-411 mln vs. 418 mln consensus when normalizing for the negative impact of foreign currency of 4.8 million and a loss of revenue of 5.3 million in 2017 due to planned distribution restructuring in Brazil and Puerto Rico and the wind down of a non-core business, the growth rate is expected to be 1.5 to 2.5. Additionally, the Company expects full year 2017 adjusted EBITDA margins to be generally consistent with 2016 8:00 am Arcadia Biosciences obtains U. S. FDA GRAS status for SONOVA GLA safflower oil ( RKDA ). Co announces that the FDA has accepted its conclusion that its SONOVA GLA safflower oil is quotgenerally recognized as safequot for use in nutritional beverages and medical foods. Arcadia produces GLA safflower nutritional oils with high concentrations of gamma-linolenic acid (:GLA). These oils are marketed by Arcadia under the SONOVA brand and are currently used in nutritional supplement products. 7:59 am On The Wires (:WIRES). CGI (GIB) announced it has won a new three year, 5 million, contract with Englands Environment Agency to design, deliver and run Englands new Future Flood Forecasting System. Flood Forecasting System will make use of the latest scalable cloud computing, enabling the Environment Agency to produce and share flood forecasts and products with greater efficiency and effectiveness. Agrium Inc. (AGU) anNOUNCED THAT IT SUCCESSFULLY COMPLETED CONSTRUCTION OF THE UREA PLANT AT ITS NITROGEN FACILITY IN BORGER, TEXAS, WITHIN THE PREVIOUSLY DISCLOSED REVISED TIME LINE AND COST PARAMETERS. COMMISSIONING OF THE NEW 610,000 TONNE UREA FACILITY, OF WHICH 100,000 TONNES OF UREA TONNE EQUIVALENT WILL BE DIESEL EXHAUST FLUID, IS UNDERWAY AND PRODUCTION IS EXPECTED TO COMMENCE IN THE FIRST QUARTER OF 2017.SERA PROGNOSTICS ENTERED INTO A STRATEGIC COLLABORATION WITH LABORATORY CORPORATION OF AMERICA (LH) TO BE THE EXCLUSIVE U. S. DISTRIBUTOR OF SERAS PRETRM TEST. IN ADDITION, LABCORP WILL LEAD SERAS 40 MLN SERIES C FINANCING. PROCEEDS FROM THE SERIES C FINANCING, WHICH INCLUDES EXISTING INVESTORS, ENABLE SERA TO CONTINUE BUILDING CLINICAL EVIDENCE TO SUPPORT REIMBURSEMENT AND INSURANCE COVERAGE DECISIONS, AS WELL AS EXPAND COMMERCIALIZATION NATIONWIDE FOR THE PRETRM TEST. WINGSTOP (WING) BECAME THE FIRST RESTAURANT BRAND TO OFFER VOICE-ACTIVATED ORDERING WITH MENU ITEM CUSTOMIZATION THROUGH AMAZON (AMZN) ALEXA. 7:58 AM CHIPOTLE MEXICAN GRILL FOLLOW UP: SEES Q4 EPS WELL BELOW CONSENSUS WITH IMPROVEMENT IN DECEMBER SALES AS COMPS EASED ADDS 100 MLN TO BUYBACK ( CMG ) : Sees Q4 EPS 0.50-0.58 vs 0.98 Capital IQ Consensus revs 1.035 bln vs 1.05 bln Capital IQ Consensus comps -4.8 vs. ests near -3.5. Comparable restaurant sales for the quarTER DECREASED 4.8, WHICH INCLUDES THE BENEFIT OF 0.5 RELATED TO PREVIOUSLY DEFERRED REVENUE THAT WAS RECOGNIZED IN THE FOURTH QUARTER. COMPARABLE RESTAURANT SALES DECREASED 20.2 IN OCTOBER 2016, DECREASED 1.4 IN NOVEMBER 2016, AND INCREASED 14.7 IN DECEMBER 2016. SALES COMPARISONS ARE LAPPING AN EASIER COMPARE DUE TO LOWER SALES LEVELS IN NOVEMBER AND DECEMBER 2015. OPERATING MARGIN 13-14. quotDuring the quarter we incurred higher expenses compared to our originally-forecaSTED AMOUNTS IN OTHER OPERATING COSTS, DRIVEN BY INCREASED PROMOTIONAL SPEND AND COSTS RELATED TO TESTING TELEVISION ADVERTISING. OUR MARKETING AND PROMOTIONAL EXPENSES DURING THE QUARTER TOTALED 4.7 OF SALES. WE ALSO INCURRED HIGHER FOOD COSTS COMPARED TO OUR ORIGINALLY-FORECASTED AMOUNTS AS A RESULT OF INCREASED MARKET COSTS FOR AVOCADOS. quot This report is also filed to announce that Chipotles Board of Directors has authorized repurchases of Chipotle common stock with a total aggregate purchase price of 100 million, exclusive of commissions. This repurchase is in addition to previously announced repurchase authorizations totaling 2.1 billion. 7:52 am Chipotle Mexican Grill moving lower by 3 on downside guidance Q4 comps -4.8 ( CMG ). Sees Q4 EPS of 0.50-0.58 vs 0.98 Capital IQ Consensus Estimate revs 1.035 bln vs 1.05 bln Capital IQ Consensus Estimate comps -4.8. 7:48 am Healthways changes name to Tivity Health will begin trading under its new ticker TVTY on January 11 ( HWAY ). 7:32 am Zimmer Biomet sees Q4 sales of approx 2.013 bln, Capital IQ consensus 1.971 bln sees FY16 EPS at upper end of prior guidance ( ZBH ). Expects fourth quarter net sales to be approximately 2.013 billion (Capital IQ consensus 1.971 bln), an increase of 4.1 over the prioR YEAR PERIOD. ON AN ADJUSTED, CONSTANT CURRENCY BASIS, REVENUE INCREASED BY 4.4 OVER THE PRIOR YEAR PERIOD, WITH THE RECENTLY ACQUIRED LDR HOLDING CORPORATION CONTRIBUTING APPROXIMATELY 230 BASIS POINTS. PREVIOUSLY, THE COMPANY HAD ESTIMATED FOURTH QUARTER REVENUE GROWTH TO BE IN A RANGE OF 1.0 TO 2.0 ON A SIMILAR BASIS. PRELIMINARY FULL YEAR NET SALES ARE PROJECTED TO BE 7.684 BILLION, AN INCREASE OF 28.1 OVER THE PRIOR YEAR. FY16 REVENUES INCREASED BY 2.3 ON A CONSTANT CURRENCY, ADJUSTED PRO FORMA BASIS, EXCLUDING THE CONTRIBUTION FROM THE LDR TRANSACTION. PREVIOUSLY, THE COMPANY HAD ESTIMATED FULL YEAR REVENUE GROWTH TO BE IN A RANGE OF 1.65 TO 1.90 ON A SIMILAR BASIS. THE COMPANY IS UNABLE TO PROVIDE UPDATED GAAP (REPORTED) GUIDANCE FOR FULL-YEAR 2016 DILUTED EARNINGS PER SHARE, WITHOUT UNREASONABLE EFFORTS, AS THE COMPANY IS FINALIZING THE ACCOUNTING FOR CERTAIN INTEGRATION-RELATED ITEMS THAT ARE EXCLUDED FROM THE COMPUTATION OF ADJUSTED DILUTED EARNINGS PER SHARE. THE COMPANY NOW EXPECTS FULL YEAR 2016 ADJUSTED DILUTED EARNINGS PER SHARE TO BE TOWARDS THE UPPER END OF THE PREVIOUSLY ESTIMATED RANGE OF 7.90 TO 7.95. 7:31 AM FIRSTSERVICE ACQUIRES PAUL DAVIS NATIONAL TERMS NOT DISCLOSED ( FSV ) : Paul Davis National is a specialized commercial and large loss operation within Paul Davis Restoration. The terms of the transaction were not disclosed. 7:31 am WNS to acquire Denali Sourcing Services for 40 mln in cash expects to be accretive to fiscal 2017 earnings ( WNS ) : Denali Sourcing Services is a provider of strategic procurement BPM solutions. The acquisition of Denali Sourcing Services expected to close in Jan 2017. Cash consideration for the transaction is 40.0 mln plus adjustments for cash and working capital. WNS intends to fund the consideration primarily with long-term debt. The acquisition is expected to contribute 3 mln in rev for WNS in the fiscal year ending Mar 31, 2017, and to be accretive to fiscal 2017 earnings. 7:30 am Coupa Software acquires Spend360 International terms not disclosed ( COUP ). Based outside London, Spend360 is an analytics solution that uses deep machine learning and artificial intelligence to structure and cleanse data in a format that finance and procurement can actually use. Coupa expects the capabilities from Spend360 to be made available to select Coupa customers later this year. The acquisition is not expected to have a material impact on Coupas results of operations or financial condition for its fourth quarter or fiscal year ending January 31, 2017. 7:30 am Ascena Retail Group (halted) reports holiday comps down 3.1 lowers Q2, FY17 EPS guidance below consensus ( ASNA ). Reports holiday comps down 3.1 (guided quarter down 4-5)Ann Taylor -8.2, Loft -1.8, Maurices -7.1, Dressbarn -4.6, Lane Bryant -5.1, catherines 1.6Lowers Q2 EPS to (0.11-0.08) from (0.05)-0.00 vs (0.03) Capital IQ Consensus. LOWERS FY17 EPS TO 0.37-0.42 FROM 0.60-0.65 VS. 0.58 CONSENSUS. 7:30 AM ON THE WIRES (:WIRES). ENERGY FUELS INC. (UUUU) ANNOUNCED THAT THE U. S. BUREAU OF LAND MANAGEMENT HAS ISSUED A FINAL ENVIRONMENTAL IMPACT STATEMENT AND RECORD OF DECISION (THE quotRODquot) for the Companys 100-owned Sheep Mountain Project located in the Crooks Gap Mining District of central Wyoming. The Sheep Mountain Project is a large-scale, formerly-producing, conventional uranium mine with the potential to become a long-term uranium production center in a higher price environment. The issuance of the EIS, the ROD and the Mine Permit are the last major government approvals required to commence mining at this project, as the Company continues to evaluate options for processing the resources that may be mined at the project, including toll processing at other facilities in the region and the licensing and construction of its own onsite facility. Brown Gibbons Lang amp Company announced the sale of Groot Industries to Waste Connections (WCN). BGLs Environmental amp Industrial Services team served as the financial advisor to Groot in the transaction. The specific terms of the transaction were not disclosed. 7:27 am Visteon in slide presentation sees FY16 amp FY17 guidance in line with estimates ( VC ). Co issues in-line guidance for FY16 (Dec), sees FY16 (Dec) revs of 3.1 bln vs. 3.11 bln Capital IQ Consensus Estimate sees adjusted EBITDA of 340-345 mlnCo issues in-line guidance for FY17 (Dec), sees FY17 (Dec) revs of 3.1-3.2 bln vs. 3.18 bln Capital IQ Consensus Estimate sees adjusted EBITDA of 355-370 mln 7:21 am European Markets Update: FTSE 0.4, DAX 0.2, CAC UNCH (:SUMRX) : Major European indices trade with slim gains while Spains IBEX (-0.7) underperforms. In Germany, Jorg Meuthen, who is the economist for the right-wing AFD party, said the Eurozone could be split into two separate currency unions-a stronger one clustered around Germany while a weaker one would be clustered around France. Recall that Marine Le Pen, who is expected to be in a tight three-way race for French presidency in April, has voiced support for significant changes to the structure of the eurozone. Economic data was limited: Frances November Industrial Production 2.2 month-over-month (expected 0.6 last -0.1) Swiss December Unemployment Rate held at 3.3, as expected ---Equity Markets--- UKs FTSE is higher by 0.4 with miners showing relative strength. Anglo American, Rio Tinto, BHP BillitON, ANTOFAGASTA, AND FRESNILLO POSTED GAINS BETWEEN 2.3 AND 6.4. CONSUMER NAMES HAVE ALSO CONTRIBUTED TO THE ADVANCE WITH TESCO, MORRISON SUPERMARKETS, INTERCONTINENTAL HOTELS, MERLIN ENTERTAINMENTS, NEXT, AND SAINSBURY ADDING BETWEEN 1.8 AND 4.7. HOMEBUILDERS TAYLOR WIMPEY, PERSIMMON, AND BARRATT DEVELOPMENTS ARE UP BETWEEN 1.3 AND 1.8. GERMANYS DAX HAS ADDED 0.2. SIEMENS HAS JUMPED 1.7 IN REACTION TO AN UPGRADE. WHILE EXPORTERS CONTINENTAL AND VOLKSWAGEN HOLD RESPECTIVE GAINS OF 1.8 AND 1.3. FINANCIALS HAVE BEEN WEAK WITH COMMERZBANK AND DEUTSCHE BANK DOWN 2.2 AND 2.7, RESPECTIVELY. FRANCES CAC SITS JUST ABOVE ITS FLAT LINE, LOOKING TO AVOID ITS SECOND CONSECUTIVE DECLINE. RECENT STRENGTH IN COMMODITY PRICES HAS SENT ARCELORMITTAL TO THE TOP OF THE DAYS LEADERBOARD WITH A GAIN OF 2.5. AUTOMAKERS RENAULT AND PEUGEOT ARE UP 2.3 AND 0.6, RESPECTIVELY, WHILE FINANCIALS ARE MIXED. SOCIETE GENERALE HAS ADDED 0.7 WHILE CREDIT AGRICOLE AND BNP PARIBAS ARE BOTH DOWN NEAR 0.2. COUNTERCYCLICAL NAMES LIKE ORANGE AND VEOLIA ENVIRONNEMENT LAG, DOWN 1.4 AND 2.4, RESPECTIVELY. SPAINS IBEX TRADES LOWER BY 0.7 AMID WEAKNESS IN FINANCIALS. BANCO POPULAR, BBVA, BANKIA, BANCO SABADELL, AND CAIXABANK ARE DOWN BETWEEN 0.6 AND 2.8. 7:21 AM DEUTSCHE LUFTHANSA AG REPORTS DECEMBER TRAFFIC DATA ( DLAKY ). Co reported total December passengers of 7.79 mln, up 5.9 YoY. Available seat kilometers 20.931 mln, up 5.4 YoY. Cargo Load Factor of 70.3 vs 66.6 last year. 7:18 am Nabors Industries prices 500 mln private offering of its 0.75 exchangeable senior unsecured notes due 2024 ( NBR ). The net proceeds from the offering will be used to prepay the remaining balance of NIIs unsecured term loan, which matures in 2020, as well as to pay the cost of the capped call transaction entered into with respect to Nabors common shares. Any remaining net proceeds from the offering will be used for general corporate purposes, including TO REPURCHASE OR REPAY OTHER INDEBTEDNESS. THE NOTES WILL BEAR INTEREST AT A RATE OF 0.75YEAR UNTIL MATURITY, PAYABLE SEMI-ANNUALLY IN ARREARS ON JAN 15 AND JULY 15 OF EACH YEAR, BEGINNING ON JULY 15, 2017. THE NOTES WILL BE EXCHANGEABLE, UNDER CERTAIN CONDITIONS, AT AN INITIAL EXCHANGE RATE OF 39.7488 COMMON SHARES OF NABORS PER 1,000 PRINCIPAL AMOUNT OF NOTES, SUBJECT TO ADJUSTMENT, WHICH REPRESENTS AN 40.0 EXCHANGE PREMIUM OVER THE LAST REPORTED SALE PRICE OF 17.97 PER COMMON SHARE OF NABORS ON THE NYSE ON JAN 9, 2017. NABORS AND NII ENTERED INTO PRIVATELY NEGOTIATED CAPPED CALL TRANSACTIONS WITH ONE OR MORE OF THE INITIAL PURCHASERS ANDOR THEIR AFFILIATES. THE CAPPED CALL TRANSACTIONS COVER THE NUMBER OF NABORS COMMON SHARES THAT WILL INITIALLY UNDERLIE THE NOTES. THE CAPPED CALL TRANSACTIONS ARE EXPECTED TO REDUCE POTENTIAL DILUTION TO NABORS COMMON SHARES ANDOR OFFSET POTENTIAL CASH PAYMENTS NABORS IS REQUIRED TO MAKE IN EXCESS OF THE PRINCIPAL AMOUNT UPON ANY EXCHANGE OF NOTES. SUCH REDUCTION ANDOR OFFSET IS SUBJECT TO A CAP REPRESENTING A PRICE PER SHARE OF 31.4475, AN 75.0 PREMIUM OVER THE LAST REPORTED SALE PRICE OF 17.97COMMON SHARE OF NABORS ON THE NYSE ON JAN 9, 2017. 7:09 AM NEXSTAR EXTENDS THE EMPLOYMENT AGREEMENT OF CFO THOMAS E. CARTER THROUGH DECEMBER 31, 2021 EXTENSION SUPERSEDES CARTERS PRIOR EMPLOYMENT AGREEMENT WHICH WAS TO CONCLUDE IN AUGUST 2018 ( NXST ). 7:02 am Pluristem Therapeutics announced that its Phase III study of its PLX-PAD cells in the treatment of critical limb ischemia was cleared by the FDA expects to begin enrolling patients in its Phase III study in both the U. S. and Europe during 1H17 ( PSTI ). 7:02 am Evolving Systems (thinly-traded) announces that one of the market-leading wireless carriers in Southeast Asia has selected its Acquisition and Activation Managed Service to support its base of 60 mln subscribers ( EVOL ). 7:02 am Electro ScienTIFIC REPORTS PRELIMINARY Q3 ORDERS ARE EXPECTED TO BE 42-44 MLN ( ESIO ) : In conjunction with todays presentation at the Needham Growth Conference. the company is announcing that preliminary orders for its 3Q17 are expected to be 42-44 mln. Cash and investments at the end of the quarter are expected to be 54-55 million. The company also announced that on January 9, 2017, it closed a 14 million ten-year term loan with First Technology Federal CREDIT UNION IN BEAVERTON, OREGON. 7:02 AM PIXELWORKS SEES Q4 REVS AT HIGH END OF GUIDANCE, EXPECTS TO REPORT GAAP PROFITABILITY ( PXLW ). Co sees Q4 revs of approximately 16 mln (Guidance was for 15-16 mln) vs 15.49 mln Capital IQ Consensus Estimate. The Company also expects to report a profit for the fourth quarter on a fully diluted GAAP basis, compared to previous guidance of a loss of 0.06 per share to breakeven. Additionally, the Company generated cash from operations in the fourth quaRTER AND ANTICIPATES A QUARTER-END CASH BALANCE OF APPROXIMATELY 19.6 MILLION, NET OF ANY BORROWING, WHICH IS APPROXIMATELY 3 MILLION GREATER THAN AT THE END OF THE THIRD QUARTER. 7:02 AM GILDAN ACTIVEWEAR HAS EMERGED AS THE WINNER IN THE COURT SUPERVISED AUCTION TO ACQUIRE THE AMERICAN APPAREL BRAND AND CERTAIN ASSETS FROM AMERICAN APPAREL, LLC (:APPCQ) FOR 88 MLN IN CASH ( GIL ). The transaction is subject to Bankruptcy Court approval on January 12, 2017 and Gildan anticipates completing the acquisition by early February. The Company will provide details on the projected financial contribution of the acquisition on the Companys earnings in February, when it reports its full year 2016 earnings results and initiates guidance for 2017. 7:01 am xG Technology regains full compliance with all listing requirements of the Nasdaq ( XGTI ). 7:01 am NeuroMetrix reports Q4 demand for its Quell Technology, invoiced value of shipments totaled approximately 3.5 mln (19 QQ) ( NURO ). The Quell invoiced value in Q4 2016 reflects shipments of approximately 14,300 devices and 20,000 reorder electrodes, a growth rate of 18 in devices and 39 in electrodes from Q3 2016. To date, the Company has shipped nearly 60,000 devices. 7:01 am Abbott Labs announces CE mark for its Alinity S blood and plasma screening system ( ABT ) : The Alinity s System will help transform the blood and plasma screening process in terms of speed, capacity and quotwalk-awayquot time (i. e. when lab professionals are free to manage other responsibilities while the instrument processes samples without direct interaction) as a result of a number of new features: Expands capacity to run up to 600 tests per hour, at least twice as much as competitive standalone instruments. Improves centers ability to track all activities and actions associated with the testing and processing of each donation in accordance with relevant legislation and requirements. Increases walk-away time to a minimum of three hours. Gives laboratory professionals the ability to continuously load and unload samples and supplies without pausing or stopping the system. Features an intuitive software interface, menu design and sample loading layout, shared with other Alinity instruments, making it easy for lab technicians to learn and use. 7:01 am NovoCure reports prelim Q4 results 1,091 active patients at Dec. 31, 2016, an increase of 80 YY ( NVCR ). There were 1,091 active patients on Optune therapy on Dec. 31, 2016, an increase of 80 percent VERSUS DEC. 31, 2015. OF THE ACTIVE PATIENTS, 835 WERE IN THE U. S. AND 256 WERE IN NOVOCURES EMEA MARKETS. 706 PRESCRIPTIONS WERE RECEIVED IN THE FOURTH QUARTER OF 2016, AN INCREASE OF 27 PERCENT VERSUS THE FOURTH QUARTER OF 2015. 544 OF THE PRESCRIPTIONS WERE RECEIVED IN THE U. S. AND 162 WERE RECEIVED OUTSIDE OF THE U. S. PRIMARILY IN EUROPE. quotThe fourth quarter of 2016 was the eighth consecutive quarter of active patient growth for Novocure since the presentation of our successful EF-14 phase 3 pivotal trial data in newly diagnosed glioblastoma (:GBM),quot said Asaf Danziger, Novocures Chief Executive Officer. quotAs of Dec. 31, 2016, we had nearly 1,100 active patients on treatment, including 256 patients in EMEA, reflecting the increasing importance of our non-U. S. markets. quot quotThe fourth quarter of 2016 was also marked by significant clinical milestones. A long-term analysis of the EF-14 data, presented at the 21st Annual Scientific Meeting of the Society for Neuro-Oncology in November, demonstrated a 70 percent improvement in survival rate at four years for patients treated with Optune together with temozolomide compared to patients treated with temozolomide alone. During our RampD day, we also shared topline results from phase 2 pilot studies in advanced pancreatic cancer, recurrent ovarian cancer and mesothelioma, suggesting that Tumor Treating Fields, when added to standard of care treatments, may improve patient outcomes. quot 7:00 am Investment Tech reports December 2016 trading volume was 3.1 bln shares, -6 YY, AND ADV WAS 150 MLN SHARES, -6 YY ( ITG ) : There were 21 trading days in both December 2016 and November 2016 and 22 trading days in December 2015. 6:59 am On The Wires (:WIRES). BioLife Solutions (BLFS) announced that it has reached an agreement to extend the maturity date and repayment schedule of its outstanding 4 million credit facility. Denison Mines Corp. (DNN) announced that it has executed an agreement with the partners of the Wheeler River Joint Venture that will result in an increase in Denisons ownership of the Wheeler River project to up to approximately 66 (currently 60) by the end of 2018. The Wheeler River property is a joint venture between Denison (60 ownership and operator), Cameco Corp. (30 ownership), and JCU Canada Exploration (10 ownership). Under the terms of the Agreement, the JV Parties have agreed to allow for a one-time election by Cameco to fund 50 of its ordinary share of joint venture expenses in 2017 and 2018. Transenterix (TRXC) says it is on track to file the 510(k) for the Senhance System in early 2017 and expects to receive clearance in late 2017.Richmont Mines (RIC) announced that it will transfer the listing of its common shares from NYSE MKT to the New York Stock Exchange (:NYSE). 6:56 am Endeavour Silver reports 2016 production of 5.4 mln oz silver and 57,375 oz gold, slightly above guidance on gold and slightly below guidance on silver ( EXK ). Silver equivalent production totalled 9.7 million oz at a 75:1 silver: gold ratio, in line with guidance. Silver production in 4Q16 was 1,088,845 oz and gold production was 44,402 oz, for silver equivalent production of 1.9 million oz. Co expects to release updated reserve and resource estimates and 2017 production and cost guidance within the next two weeks. 6:55 am Asian Markets Close: Nikkei -0.8, Hang Seng 0.8, Shanghai -0.3 (:SUMRX) : Equity indices in the Asia-Pacific region ended Tuesday on a mostly lower note. The yen advanced against the dollar in overnight action, but that move has been retraced entirely. In China, December PPI (5.5 year-over-year expected 4.5) climbed to a five-year high while inflation on the consumer level (2.1 year-over-year expected 2.3) was cooler than expected. The National Development and Reform Commission said that uncertainty will be on the rise in 2017, but the government will continue keeping tabs on economic performance. In economic data: Chinas December PPI 5.5 year-over-year (consensus 4.5 last 3.3). December CPI 0.2 month-over-month (expected 0.3 last 0.1) 2.1 year-over-yeAR (CONSENSUS 2.3 PREVIOUS 2.3) JAPANS DECEMBER HOUSEHOLD CONFIDENCE 43.1 (EXPECTED 41.3 LAST 40.9) AUSTRALIAS NOVEMBER RETAIL SALES 0.2 MONTH-OVER-MONTH (EXPECTED 0.4 LAST 0.5) ---EQUITY MARKETS--- JAPANS NIKKEI LOST 0.8 AFTER BEING CLOSED ON MONDAY. FAST RETAILING, OKI ELECTRIC, DAI-ICHI LIFE INSURANCE, KONAMI, ISUZU MOTORS, HINO MOTORS, CREDIT SAISON, AND NGK INSULATORS LOST BETWEEN 1.8 AND 2.6. ON THE UPSIDE, SONY, TOKYO ELECTRON, AND DENTSU POSTED GAINS BETWEEN 1.2 AND 2.4. HONG KONGS HANG SENG CLIMBED 0.8 WITH SUPPORT FROM MOST COMPONENTS. PROPERTY NAMES LIKE SINO LAND, NEW WORLD DEVELOPMENT, HENDERSON LAND, CHEUNG KONG PROPERTY HOLDINGS, AND CHINA RESOURCES LAND ADVANCED BETWEEN 1.0 AND 1.9. TELECOM NAMES LAGGED WITH CHINA UNICOM HONG KONG FALLING 2.3 AND CHINA MOBILE SHEDDING 0.3. CHINAS SHANGHAI COMPOSITE SLIPPED 0.3. GITI TIRE, SHANGHAI MATERIAL TRADING, GREATTOWN HOLDINGS, AND SHANGHAI DIESEL ENGINE FELL BETWEEN 4.4 AND 5.8. INDIAS SENSEX ADVANCED 0.7 WITH GROWTH-SENSITIVE NAMES LEADING THE RALLY. ADANI PORTS, TATA MOTORS, TATA STEEL, AND ASIAN PAINTS ADDED BETWEEN 1.5 AND 3.3. FINANCIALS WERE MOSTLY HIGHER WITH HDFC BANK, ICIC BANK, AND SBI RISING BETWEEN 0.3 AND 1.5 WHILE AXIS BANK LOST 1.2. ---FX--- USDJPY UNCH AT 115.95 USDCNY -0.2 TO 6.9226USDINR UNCH AT 68.173 6:50 AM VISTEON ANNOUNCES A NEW 400 MLN SHARE REPURCHASE AUTHORIZATION ( VC ). 6:45 am Express SEES Q4 COMPS BELOW GUIDANCE REAFFIRMS EPS ( EXPR ). Co sees Q4 comps down 13 vs. negative low double digit guidance reaffirms Q4 EPS 0.26-0.30 vs 0.29 Capital IQ Consensus. quotBased on our holiday results, we are reaffirming our fourth quarter and full year EPS guidance. Our store performance continues to be impacted by challenging mall traffic trends and a more promotional retail environment. However, we remain pleased with our e-commerce sales performance, which continues to trend positively year-over-year. quot 6:45 am Teleflex annouNCES ITS ARROW VPS RHYTHM DEVICE WITH OPTIONAL TIPTRACKER TECHNOLOGY HAS BEEN ISSUED 510(K) CLEARANCE TO COMMERCIALIZE THE DEVICE IN THE US ( TFX ). 6:41 am West Marine in slide presentation sees FY16 revs in line with consensus ( WMAR ). Co issues in-line guidance for FY16 (Dec), sees FY16 (Dec) revs of down 1 to flat to 697-710 mln vs. 703.45 mln Capital IQ Consensus Estimate sees comps flat to 1 6:36 am Prestige Brands repeats FY17 EPS and revenue guidance in slide presentation ( PBH ). Co repeats guidance for FY17 (MAR), SEES EPS OF 2.30-2.36 VS. 2.34 CAPITAL IQ CONSENSUS ESTIMATE SEES FY17 (MAR) REVS OF 4.5-6.0 TO 842.5-854.4 MLN VS. 844.06 MLN CAPITAL IQ CONSENSUS ESTIMATE CO SEES ADJUSTED CASH FLOW GUIDANCE OF 190 MLN OR MORE. 6:31 AM SOUTHWEST AIR REPORTS DEC TRAFFIC RAISES Q4 UNIT REV GUIDANCE ( LUV ). ASMs increased 4.8 to 12.6 bln in DEC 2016, COMPARED WITH DEC 2015 ASMS OF 12.1 BLN. THE DEC 2016 LOAD FACTOR WAS 82.6, COMPARED WITH 83.0 PERCENT IN DEC 2015. BASED ON THESE RESULTS AND AN IMPROVEMENT IN CLOSE-IN YIELDS, THE CO NOW ESTIMATES ITS FOURTH QUARTER 2016 OPERATING REV PER ASM WILL DECLINE IN THE 3.0 TO 4.0 RANGE (PRIOR 4-5), AS COMPARED WITH FOURTH QUARTER 2015. THE COMPANY FLEW 10.4 BILLION REVENUE PASSENGER MILES IN DEC 2016, AN INCREASE OF 4.2 PERCENT FROM THE 10.0 BILLION RPMS FLOWN IN DEC 2015. 6:22 AM STRONGBRIDGE BIOPHARMA JANUARY PRESENTATION SLIDES ( SBBP ). Launch of Keveyis expected in April 2017. Keveyisis the first and only FDA-approved therapy indicated for the treatment of:Primary hyperkalemic periodic paralysisPrimary hypokalemic periodic paralysisRelated variantsCOR-003 SONICS trial expected to be fully enrolled by end of Q2 2017. REPORTING OF TOP-LINE DATA ANTICIPATED IN Q1 2018. INITIATION OF A SECOND PHASE 3 CLINICAL TRIAL (:LOGICS) FOR COR-003 WITH EXPECTED REPORTING OF TOP-LINE DATA IN 2018. REVENUE GENERATING STARTING IN Q2 2017 6:11 AM HEALTHEQUITY REPEATS FY17 EPS AND REVENUE GUIDANCE IN SLIDE PRESENTATION ( HQY ). Co repeats guidance for FY17 (Jan), sees EPS of 0.38-0.42 may not compare to 0.51 Capital IQ Consensus Estimate sees FY17 (Jan) revs of 174-178 mln vs. 177.31 mln Capital IQ Consensus Estimate sees adjusted EBITDA of 59-62 mln co reported 671 network partners. 6:06 am Kona Grill sees Q4 revs below consensus Q4 comps -4.1 ( KONA ). Co issues downside guidance for Q4 (Dec), sees Q4 (Dec) revs of 43.6 mln vs. 45.72 mln Capital IQ Consensus Estimate. Same-store sales decreased 4.1 compared to an increase of 3.2 in the fourth quarter of 2015. quotSimilar to many of our restaurant peers, same-store sales for the fourth quartER WERE WEAKER THAN WE HAD ANTICIPATED AS WE TOO DID NOT EXPERIENCE A POST-ELECTION DAY SALES BOUNCE. WEAK RETAIL TRAFFIC, INCLEMENT WEATHER AND AN INFLUX OF NEW COMPETITION AS WELL AS CONTINUED WEAKNESS IN OIL-IMPACTED MARKETS CONTRIBUTED TO THE SOFT SALES. IN ADDITION, WE CYCLED OVER OUR MOST DIFFICULT QUARTERLY COMPARISON OF 2016 WHICH MADE ACHIEVING POSITIVE SAME-STORE SALES EVEN MORE CHALLENGING. quot 6:04 am Del Friscos Restaurant OFFERS PRELIM Q4 RESULTS AHEAD OF PRESENTATION AT 19TH ANNUAL ICR CONFERENCE ( DFRG ). Co sees Q4 revs 119-119.2 mln vs 117.45 mln Capital IQ CONSENSUS ESTIMATE, COMPS 0.8 quotWe are pleased that all three concepts posted positive comparable restaurant sales for the quarter with positive traffic at both Del Friscos Grille and Sullivans Steakhouse despite a negative drag to total comparable sales of 1.1 due to restaurants in oil challenged markets. In 2017 we will have several initiatives underway to enhance our understanding of our consumer, drive top-line growth and improve flow-thru at our existing restaurants while limiting development. We firmly believe this approach will pay long-term dividends for the benefit of all shareholders and enable us to ramp up growth in 2018 and beyond with improved returns on invested capital. quotquotFor fiscal year 2017, we will be opening three restaurants including a Del FriscoS DOUBLE EAGLE STEAK HOUSE IN PLANO, TX AND DEL FRISCOS GRILLES IN DOWNTOWN NEW YORK CITY AND WESTWOOD, MA. quot 6:02 am Valeant Pharma announces positive results from a second confirmatory pivotal Phase 3 study to assess the safety and efficacy of IDP-118 lotion in the treatment of plaque psoriasis ( VRX ). Within the Phase 3 study of 203 adult subjects with moderate to severe psoriasis, IDP-118 showed statistical significance (p lt 0.001) to vehicle with a treatment success rate at 8 weeks of 35.76 to 6.98. The primary endpoint of the 12-week study (8 weeks of treatment followed by 4 weeks of follow-up) was achievement of a quotclearquot to quotalmost clearquot score and at least a 2 grade improvement based on aN INVESTIGATOR GLOBAL ASSESSMENT ( IGA ) at 8 weeks, and clear to almost clear and at least 2 grade improvement in the IGA at weeks 12, 6, 4 and 2 as secondary endpoints. 5:57 am SampP futures vs fair value: 1.80. Nasdaq futures vs fair value: 3.60. 5:57 am European Markets. FTSE. 7259.97. 22.20. 0.30. DAX. 11589.26. 25.30. 0.20. 5:57 am Asian Markets. Nikkei. 19301. -152.90. -0.80. Hang Seng. 22745. 186.20. 0.80. 5:50 am NanoString Technologies receives positive assessment for NanoStrings Prosigna Blue Cross Blue Shield Association ( NSTG ) : Co announced that the Blue Cross Blue Shield Association Evidence Street has issued a positive assessment of the Prosigna Breast Cancer Gene Signature Assay. Evidence Street pioneered the development of scientific criteria for assessing medical technologies through comprehensive reviews of clinical evidence. The positive Evidence Street assessment is in line with updated ASCO guidelines released in February 2016. The ASCO guidelines recommend the use of the Prosigna Breast Cancer assay to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer with known hormone receptor and HER2 status. 5:47 am General Moly CFO to depart in May ( GMO ) : Co announced that effective May 12, 2017 Lee Shumway, Chief Financial Officer and Principal Accounting Officer, will depart from the Company. Shumway informed the Company last week that effective July 1, 2017 he quothas accepted the call from The Church of Jesus Christ of Latter-day Saints to serve as one of the Churchs international mission presidents. quotThrough mid-May, Shumway will continue with the Company in his current roles. 5:46 am Veolia Environnement awarded two platform decommissioning contracts for recycling ( VEOEY ). Veolia and its partner Peterson have been awarded two platform decommissioning contracts for recycling at their facility in Great Yarmouth, England. With an aim of reaching 96 recycling rates the work to recycle materials and assets is expected to begin in spring 2017 when the platforms arrive onshore. 5:43 am On The Wires (:WIRES). The Chemours Company (CC) announced it has entered into an agreement to sell The DuPont Building to The BucciniPollin Group, a privately held, full-service real estate acquisition, development, and management company. Shutterstock (SSTK) announced that it has expanded its milestone multi-year deal with The Associated Press. Beginning this week, Shutterstock will distribute APs daily global photo output for license to customers based in the United Kingdom. Shutterstocks enterprise customers in the United Kingdom will have access to over 30 million photos from AP Images. FTI Consulting (FCN) announced the appointment of Romain Bgramian as a Senior Managing Director in the Corporate Finance amp Restructuring segment in Paris. Amazon (AMZN) and Xilam Animation announced a multi-year content deal that makes Amazon Prime Video India the exclusive subscription streaming home of all four existing and three upcoMING SEASONS OF THE IMMENSELY POPULAR ANIMATED SERIES OGGY amp THE COCKROACHES AND ZIG amp SHARKO. CLEARINK DISPLAYS TODAY ANNOUNCED THAT THEY SIGNED A COMPREHENSIVE MATERIALS DEVELOPMENT AGREEMENT WITH MERCK KGAA (MKGAY) FOCUSED ON BRINGING CLEARINKS INNOVATIVE, PATENTED, REFLECTIVE DISPLAY TECHNOLOGY TO MARKET BY THE END OF 2017. FUJITSU LABORATORIES (FJTSY) HAS ANNOUNCED DEVELOPMENT OF THE WORLDS FIRST SLIDE-STYLE PALM VEIN AUTHENTICATION TECHNOLOGY. THIS TECHNOLOGY IS COMPACT ENOUGH TO BE EQUIPPED TO FUTURE TABLETS AND OTHER HANDHELD MOBILE DEVICES. AON PLC (AON) HAS LAUNCHED BREXIT NAVIGATOR, A BESPOKE AND PROPRIETARY THREE STEP SOLUTION DESIGNED TO HELP ORGANISATIONS QUANTIFY THE IMPACT OF BREXIT RISK EXPOSURES, AND REDESIGN RISK MANAGEMENT AND RISK FINANCING STRUCTURES. BREXIT NAVIGATOR IS SUPPORTED BY AN INTERACTIVE TOOL THAT PRESENTS SCENARIO-BASED INSIGHTS FOR EACH OF THE EU FOUR FREEDOMS: GOODS, CAPITAL, SERVICES AND PEOPLE, WHICH HELP ASSESS THE IMPACT OF BREXIT. SONY (SNE) PICTURES TELEVISION NETWORKS, ASIA ANNOUNCED A MULTI-YEAR AGREEMENT WITH FREMANTLEMEDIA INTERNATIONAL AND SYCO ENTERTAINMENT FOR THE RIGHTS TO ASIAS GOT TALENT, THE RECORD-BREAKING SERIES THAT PREMIERED FIRST ON SONYS AXN CHANNEL IN 2015. THE AGREEMENT FORMS PART OF SPT NETWORKS LONG TERM STRATEGY TO FURTHER BUILD ON ITS PIPELINE OF SUCCESSFUL ORIGINAL PRODUCTIONS. CHINA DIGITAL TV HOLDING CO (STV) ANNOUNCED THAT BEIJING CYBER CLOUD TECHNOLOGY CO, A SUBSIDIARY OF CHINA DIGITAL TV, ENTERED A CAPITAL INCREASE AGREEMENT WITH SHOUTAI JINXIN CAPITAL MANAGEMENT, A FUND MANAGEMENT COMPANY IN CHINA, PURSUANT TO WHICH SHOUTAI JINXIN WILL INVEST RMB33.0 MILLION IN CASH INTO CYBER CLOUD. 5:37 AM NANOSTRING TECHNOLOGIES SEES Q4 REVS BELOW CONSENSUS ( NSTG ). Co issues downside guidance for Q4 (DEC), SEES Q4 (DEC) REVS OF 24.2-25.7 MLN VS. 29.00 MLN CAPITAL IQ CONSENSUS ESTIMATE. AS SUCH, CO ISSUES downside guidance for FY16 (Dec), sees FY16 (Dec) REVS OF 85.5-87.0 MLN VS. 90.48 MLN CAPITAL IQ CONSENSUS ESTIMATE VERSUS PRIOR GUIDANCE OF 89.0-93.0 MLNOPERATIONAL HIGHLIGHTS: 140 NCOUNTER ANALYSIS SYSTEMS SOLD IN 2016, INCLUDING 60 NCOUNTER SPRINT PROFILERS INSTALLED BASE OF 480 NCOUNTER ANALYSIS SYSTEMS AT DECEMBER 31, 2016 MORE THAN 1,450 CUMULATIVE PEER-REVIEWED PUBLICATIONS OF STUDIES BASED ON NCOUNTER TECHNOLOGY AS OF DECEMBER 31, 2016 5:28 AM TAIWAN SEMI REPORTS DEC REVS OF NT78.1 BLN, UP 33.9 YOY REPORTS FY16 REVS ABOVE CONSENSUS ( TSM ). Co issues upside guidance for FY16 (Dec), sees FY16 (Dec) revs of NT947.9 bln vs. NT943.29 bln Capital IQ Consensus Estimate. 5:22 am Hecla Mining FY16 production silver 48 YoY Gold 24 YoY ( HL ) : Co reports preliminary silver and gold production results for the fourth quarter and full year 2016 that exceeded the Companys expectations. 2016 HIGHLIGHTS (compared to 2015) Silver production of 17.2 million ounces, a 48 increase. Gold production of 233,929 ounces, a 24 increase. Silver equivalent production of 46.1 million ounces, or gold equivalent production of more than 631,000 ounces, a 23 increase.2Lead production increased 6 and zinc production decreased 2. Cash, cash equivalents and short-term investments of approximately 198 million at December 31, 2016, an increase of about 43 million for the year. 4:43 am Royal Bank of Canada issues GBP500 mln of 1.125 Covered Bonds due 2021 ( RY ). 4:18 am Kite Pharma and Fosun Pharma establish JV in China to develop and commercialize autologous T-Cell Therapies Kite to Receive upfront payment of 40 mln ( KITE ) : Kite Pharma ( KITE ) and Shanghai Fosun Pharmaceutical announced a joint venture, FOSUN PHARMA KITE BIOTECHNOLOGY CO, TO DEVELOP, MANUFACTURE AND COMMERCIALIZE AXICABTAGENE CILOLEUCEL IN CHINA WITH THE OPTION TO INCLUDE ADDITIONAL PRODUCTS, INCLUDING TWO T CELL RECEPTOR PRODUCT CANDIDATES FROM KITE. AXICABTAGENE CILOLEUCEL, KITES LEAD PRODUCT CANDIDATE, IS AN INVESTIGATIONAL CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY UNDER DEVELOPMENT FOR THE TREATMENT OF B-CELL LYMPHOMAS AND LEUKEMIAS. THE JOINT VENTURE WILL BE REGISTERED IN SHANGHAI AND OWNED EQUALLY BETWEEN KITE PHARMA, A PIONEER IN THE FIELD OF ENGINEERED T-CELL THERAPY FOR CANCER, AND FOSUN PHARMA, A LEADING HEALTHCARE GROUP IN CHINA. UNDER THE TERMS OF THE AGREEMENT, FOSUN PHARMA WILL PROVIDE THE RMB EQUIVALENT OF 20 MILLION IN FUNDING TO SUPPORT CLINICAL DEVELOPMENT AND MANUFACTURING ACTIVITIES AND KITE WILL PROVIDE CERTAIN TECHNICAL TRANSFER SERVICES TO THE JOINT VENTURE. EACH PARTY WILL SHARE IN ANY PROFITS FROM THE JOINT VENTURE WITH KITE PHARMA RECEIVING 40 PERCENT AND FOSUN PHARMA RECEIVING 60 PERCENT. KITE WILL ALSO RECEIVE AN UPFRONT FEE OF 40 MILLION FROM THE JOINT VENTURE, FUNDED BY FOSUN PHARMA, REGULATORY AND COMMERCIAL MILESTONES TOTALING 35 MILLION AND MID-SINGLE DIGIT SALES ROYALTIES FOR AXICABTAGENE CILOLEUCEL. THE JOINT VENTURE WILL INITIALLY FOCUS ON AXICABTAGENE CILOLEUCEL, KITES LEAD CAR PRODUCT CANDIDATE FOR THE TREATMENT OF B-CELL LYMPHOMAS AND LEUKEMIAS. THE JOINT VENTURE WILL ALSO HAVE THE OPTION TO LICENSE ADDITIONAL PRODUCT CANDIDATES INCLUDING KITE-439, A TCR THERAPY DIRECTED AGAINST THE HUMAN PAPILLOMAVIRUS TYPE 16 E7 ONCOPROTEIN AND KITE-718, A TCR THERAPY DIRECTED AGAINST MAGE A3 AND MAGE A6, ANTIGENS FREQUENTLY FOUND IN SOLID TUMORS INCLUDING BLADDER, ESOPHAGEAL, HEAD AND NECK, LUNG AND OVARIAN CANCERS. OPT-IN AND MILESTONE PAYMENTS FOR KITE-439 AND KITE-718 COULD TOTAL 140 MILLION PLUS PROFIT SHARING AND MID-SINGLE DIGIT SALES ROYALTIES. 4:13 AM VALEANT PHARMA DIVESTS ITS CERAVE, ACNEFREE AND AMBI SKINCARE BRANDS TO LOREAL ( LRLCY ) for 1.3 bln ( VRX ) : Valeant Pharmaceuticals ( VRX ) announced that it has entered into an agreement to sell its CeraVe, AcneFree and AMBI skincare brands to LOral ( LRLCY ) for 1.3 bln in cash. The CeraVe, AcneFree, and AMBI product lines have annualized revenue of of 168 million. The CeraVe brand portfolio offers a range of advanced skincare products, including cleansers, moisturizers, sunscreens, healing ointments and a dedicated baby line. Developed with dermatologists, CeraVe is one of the fastest growing skincare brands in the U. S. with average growth over the past two years exceeding 20. The AcneFree brand portfolio offers a full range OTC cleansers and acne treatments in the U. S. introduced to the market in 1966. The AMBI brand portfolio offers a range of skincare products formulated for the needs of multicultural consumers that includes creams, cleansers and moisturizers in the face and body category. Valeant will use the proceeds from the sale to permanently repay term loan debt under its Senior Credit Facility. The transaction is expected to close in the first quarter of 2017, subject to customary closing conditions, including receipt of applicable regulatory approvals. Wachtell, Lipton, Rosen amp Katz acted as advisor to Valeant on the transaction. 4:10 am On The Wires (:WIRES). PropTiger and Housing, two of Indias leading online real estate service providers, today announced they will come together to become Indias largest online real estate services company. AS PART OF THE TRANSACTION, REA GROUP WILL INVEST 50 MILLION IN THE JOINT ENTITY, WITH AN AFFILIATE OF SOFTBANK GROUP CORP, INVESTING 5 MILLION. NEWS (NWS, NWSA) REMAINS THE LARGEST SHAREHOLDER OF PROPTIGER, AND ALSO OWNS 61.6 OF REA GROUP. REPRESENTATIVES OF REA AND SOFTBANK (SFTBY) WILL JOIN THE BOARD OF THE JOINT ENTITY, WHICH WILL CONTINUE TO BE CHAIRED BY A NEWS CORP REPRESENTATIVE. GEMALTO (GTOMY) IS PARTNERING WITH BANMA TECHNOLOGIES CO FOR THE PRODUCTION OF CHINAS FIRST INTERNET CAR -- THE ROEWE RX5. BANMA IS A NEW JOINT VENTURE BETWEEN ALIBABA GROUP (BABA) AND SAIC MOTOR CORPORATION. CHINA MOBILE (CHL) AND NUAGE NETWORKS, THE NOKIA (NOK) VENTURE FOCUSED ON SOFTWARE-DEFINED NETWORKING SOLUTIONS TO BUILD A HIGHLY-RESPONSIVE SOLUTION THAT WILL SCALE TO MEET THE NEEDS OF A MASSIVE DEPLOYMENT OF APPROXIMATELY 2000 PUBLIC CLOUD SERVERS IN THE CITIES OF BEIJING AND GUANGZHOU. SDN SOLUTION WILL INCREASE SPEED OF DEPLOYMENTS BY TEN TIMES, WHILE REDUCING OPERATING EXPENSES BY UP TO 50 HUTCHISON CHINA MEDITECH (HCM) ANNOUNCES THAT IT HAS INITIATED A PHASE I TRIAL OF ITS NOVEL SPLEEN TYROSINE KINASE INHIBITOR, HMPL-523, IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IN CHINA. THE FIRST PATIENT WAS DOSED ON DECEMBER 27, 2016. THIS STUDY COMPLEMENTS THE ONGOING PHASE I TRIAL IN PATIENTS IN AUSTRALIA WITH HEMATOLOGICAL MALIGNANCIES, WHICH IS EXPECTED TO COMPLETE DOSE-ESCALATION IN THE FIRST HALF OF 2017. BROCADE (BRCD) ANNOUNCED THAT FENG CHIA UNIVERSITY HAS SUCCESSFULLY DEPLOYED A NEW IP NETWORKING SOLUTION TO DELIVER SMART NETWORK ACCESS WITHIN ITS ON-CAMPUS STUDENT ACCOMMODATIONS. THE DECISION TO DEPLOY THE BROCADE SOLUTION REFLECTS THE STRENGTH OF ITS SOFTWARE-DEFINED NETWORKING CAPABILITIES, WHICH IS PART OF THE UNIVERSITYS STRATEGIC DIRECTION FOR ENABLING NEW NETWORK SERVICES. 4:02 AM HUANENG POWER REPORTS FY16 POWER GENERATION WITHIN CHINA DECLINED BY 2.1 YOY ( HNP ) : Co announced its power generation for the year of 2016. According to the preliminary statistics of the Company, for the fourth quarter of 2016, the Companys total power generation by its power plants within China amounted to 81.097 billion kWh on consolidated basis, representing an increase of 2.02 over the same period last year, and the total electricity sold by the Company amounted to 76.064 billion kWh, representing an increase of 1.57 over the same period last year. For the whole year of 2016, the Companys total power generation BY ITS POWER PLANTS WITHIN CHINA AMOUNTED TO 313.690 BILLION KWH ON CONSOLIDATED BASIS, REPRESENTING A DECREASE OF 2.13 OVER THE SAME PERIOD LAST YEAR, AND THE TOTAL ELECTRICITY SOLD BY THE COMPANY AMOUNTED TO 295.800 BILLION KWH, REPRESENTING A DECREASE OF 2.05 OVER THE SAME PERIOD LAST YEAR. FOR THE WHOLE YEAR OF 2016, THE COMPANYS AVERAGE ON-GRID ELECTRICITY SETTLEMENT PRICE FOR ITS POWER PLANTS WITHIN CHINA AMOUNTED TO RMB396.60 PER MWH, REPRESENTING A DECREASE OF 10.53 OVER THE SAME PERIOD LAST YEAR. FOR THE FOURTH QUARTER OF 2016, THE POWER GENERATION OF TUAS POWER LIMITED IN SINGAPORE, WHICH IS WHOLLY-OWNED BY THE COMPANY, ACCOUNTED FOR A MARKET SHARE OF 21.4 IN SINGAPORE, REPRESENTING AN INCREASE OF 0.1 PERCENTAGE POINT COMPARED TO THE SAME PERIOD OF LAST YEAR. FOR THE WHOLE YEAR OF 2016, ITS ACCUMULATED POWER GENERATION ACCOUNTED FOR A MARKET SHARE OF 21.5 IN SINGAPORE, REPRESENTING A DECREASE OF 0.2 PERCENTAGE POINT COMPARED TO THE SAME PERIOD OF LAST YEAR. 3:57 AM WILLIAMS COS PRICES 65 MLN SHARES OF COMMON STOCK AT 29.00 PER SHARE ( WMB ). 3:56 am Valeant Pharma to divest Dendreon for 819.9 mln ( VRX ) : Co announces it divests outstanding equity interests in Dendreon Pharmaceuticals to the Sanpower Group Co, one of the largest privately owned conglomerates in China. Under the terms of the transaction, Valeant will receive cash consideration of 819.9 million at completion. Dendreons first and only commercialized product is Provenge, an autologous cellular immunotherapy for prostate cancer treatment approved by the FDA in April 2010Valeant will use proceeds from the sale of Dendreon to permanently repay term loan debt under its Senior Secured Credit Facility. The transaction is expected to close in the first half of 2017, subject to customary closing conditions, including receipt of applicable regulatory approvals. 3:46 am Petrobras Brasileiro prices 4 bln in Global NOTES ( PBR ) : Co prices terms of the following: 2 bln of 6.125 Global Notes due 2022 2 bln of 7.375 Global Notes due 2027 3:25 am Pacific Continental to be acquired by Columbia Banking System ( COLB ) for 27.85 per share expected to be immediately accretive to Columbias earnings per share ( PCBK ) : Columbia Banking System ( COLB ) and Pacific Continental ( PCBK ) jointly announced the signing of a definitive agreement to merge Pacific Continental into Columbia in a transaction valued at 644.1 million, or 27.85 per share based on Columbias January 9, 2017 stock price. The combined company will have 12 billion in assets with over 150 branches throughout Washington, Oregon and Idaho. Pacific Continental shareholders are entitled to receive 0.6430 of a share of Columbia common stock for each share of Pacific Continental stock, subject to certain potential adjustments. Based on Columbias closing stock price as of January 9, 2017, the aggregate merger consideration is valued at 644.1 million, or 27.85 per share, which includes 629.5 million of Columbia stock to be issued to Pacific Continental shareholders and 14.6 million of cash to be issued to the holders of options, stock appreciation rights and restricted stock units. The value of the merger consideration will fluctuate until closing based on the value of Columbias stock and subject to a capcollar. At CLOSING, PACIFIC CONTINENTAL SHAREHOLDERS WILL OWN APPROXIMATELY 20.0 OF THE COMBINED COMPANY. THE ACQUISITION IS EXPECTED TO CLOSE IN MID-2017 AND TO BE IMMEDIATELY ACCRETIVE TO COLUMBIAS EARNINGS PER SHARE WITH 8 AND 10 PROJECTED ACCRETION IN 2018 AND 2019, RESPECTIVELY. THE TANGIBLE BOOK VALUE EARNBACK IS 3:22 AM YAMANA GOLD PROVIDES UPDATE ON LABOUR NEGOTIATIONS IN CHILE COLLECTIVE BARGAINING AGREEMENTS HAVE BEEN ENTERED ( AUY ) : Co provides an update relating to negotiations with unions at its mines in Chile. As part of the collective bargaining renewal process, tHE COMPANY HAS BEEN IN NEGOTIATIONS WITH UNIONS REPRESENTING WORKERS EMPLOYED AT EL PENON AND MINERA FLORIDA. COLLECTIVE BARGAINING AGREEMENTS HAVE BEEN ENTERED INTO AT MINERA FLORIDA, AND THE MINE AND PLANT ARE OPERATING AT FULL CAPACITY. IN RELATION TO EL PENON, THE COMPANY HAS SUCCESSFULLY ENTERED INTO A COLLECTIVE BARGAINING AGREEMENT WITH THE UNION REPRESENTING SUPERVISORS AND HAS TABLED A FINAL OFFER TO THE TWO UNIONS REPRESENTING UNDERGROUND WORKERS. THE FINAL OFFER TOOK INTO CONSIDERATION THE CURRENT COMMODITY PRICE ENVIRONMENT AND THE ONGOING EVALUATION OF THE OPTIMAL LONG-TERM PRODUCTION AND COST PROFILE AT EL PENON, ALONG WITH SEVERAL OTHER FACTORS INCLUDING RECENT COLLECTIVE BARGAINING SETTLEMENTS AT OTHER MINES IN COUNTRY INCLUDING AT MINERA FLORIDA AND AT EL PENON WITH THE SUPERVISORS. BOTH UNIONS REPRESENTING UNDERGROUND WORKERS HAVE REJECTED THE COMPANYS FINAL OFFER WITH ONE UNION ON STRIKE AND THE OTHER NOW IN A STRIKE POSITION AND EXPECTED TO STRIKE. THE COMPANY CONTINUES TO WORK WITH LOCAL AUTHORITIES AND LABOUR MINISTRY REPRESENTATIVES TO ENSURE IT PRESERVES ITS LEGAL REMEDIES AND OPTIONS INCLUDING IMPOSING A PARTIAL OR TOTAL LOCKOUT AND WITH UNION REPRESENTATIVES TO DETERMINE ANY REASONABLE RESOLUTION OF THE COLLECTIVE BARGAINING PROCESS. 3:20 AM AKERS BIOSCIENCES PRICES 1,667,000 SHARES OF COMMON STOCK AT 1.20 PER SHARE, TOGETHER WITH 833,500 FIVE-YEAR WARRANTS TO PURCHASE COMMON STOCK WITH AN EXERCISE PRICE OF 1.50 ( AKER ). 3:06 am Rent-A-Center CEO resigns Chairman appointed as interim CEO ( RCII ) : Co announced the resignation of Robert D. Davis as Chief Executive Officer and director effective immediately. Board Chairman Mark E. Speese, the Companys founder and former chief executive officer, will serve as interim CEO of the Company until a permanent successor has been named. The Board of Directors announced that it will conduct a search process to find a highly qualified candidate for CEO. 3:05 am Allegiant Travel reports Dec Traffic RPMs rise 10.3 YoY ( ALGT ) : Co reports Total System Passengers rose 15 YoY to 974,319 Revenue passenger miles (000) 888,443 10.3Available seat miles (000) 1,127,454 13.8Load Factor 78.8 (2.5 pts)Departures 7660 21.1 Guidance: January 2017 Scheduled Departures: 20 ASMs: 16